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ABSTRACT 
Bovine adenovirus 3 (BAdV-3), which belongs to the Mastadenovirus genus, is a non-
enveloped virus with an icosahedral capsid of 75 nm diameter, which wraps a double-stranded 
linear DNA genome with size of 34,446 base pairs (Reddy et al., 1999). It has been studied for 
potential application as gene delivery vector (Zakhartchouk et al., 1999). But one of the major 
limitations of adenovirus vector application is the induction of innate immune response. It has been 
reported that multiple adenoviral components could be detected by several host sensors leading to 
multi-layered innate immune response, which limit the viral infection (Hendrickx et al., 2014a, 
Thaci et al., 2011). Like many other viruses, it has also been shown that adenoviruses have 
developed strategies to modulate the innate antiviral by expression of adenoviral early proteins 
E1A, E1B, E3, E4 as well as structural proteins pVI and pVII (Avgousti et al., 2016, Burgert et 
al., 2002, Schreiner et al., 2012).   
Here, the objective of this study is to identify BAdV-3 viral proteins that are involved in 
regulating the primary signaling cascade of innate immune response. This could provide insight 
into methods of engineering BAdVs in future with attenuated innate response and enhanced 
vaccine delivery features. The initial luciferase reporter assay results of monitoring type I 
interferon (IFN) response suggest that several BAdV-3 viral proteins may act as potential 
suppressors of the interferon response. Since both pV (a core protein connecting the viral capsid 
and DNA genome) and pVIII (a structural protein connecting the core with the viral capsid) 
significantly reduced the expression of luciferase due to reduced activation of IFN- promoter in 
both cell lines tested, we choose pV and pVIII for further analysis (Ayalew et al., 2016, Gaba, 
2016).  
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Overexpression of pattern recognition receptors (RIG-1, MDA-5, TLR-3) did not increase 
the IFN- activity in cells expressing pV, suggesting that pV acts at a common step(s) of IFN- 
signaling pathways used by different PRRs. Overexpression of TBK1 but not IKK significantly 
down-regulated the IFN- promoter activity in pV expressing cells suggesting that pV may 
suppress the activation of IFN-β promoter by targeting the activity down-stream of TBK1 
activation including activation of interferon regulatory factor(s) (IRF) or at the level of IKKε 
kinase activation. Using co-immunoprecipitation assays, we demonstrated that pV interacts with 
IRF3. Further analysis using Western blotting and immunofluorescence microscopy suggested that 
expression of pV leads to significant reduction in the phosphorylation and translocation of 
transcription factor IRF3 to the nucleus. These results suggest that BAdV-3 pV modulate the 
activation of IFN- promoter by affecting the required activation of IRF3 for its transcription 
activation function. 
Although pV significantly reduced the transcription factor NF-kB or IRF7 responsive promoter 
activity, there was no effect on the nuclear translocation of NF-kB and IRF7 in the presence of pV, 
suggesting that pV may not act to modulate IFN- promoter activity by targeting NF-kB and IRF7 
transcriptional factors.  
Similar experiments using overexpression of different PRRs (RIG-1, MDA-5, TLR-3) or 
kinases (TBK1 and IKKε) in pVIII expressing cells suggested that pVIII may act down-steam of 
TBK1 and IKKε in the signaling pathway of IFN- promoter activation. Moreover, although pVIII 
significantly reduced the transcription factor NF-kB responsive promoter activity, there was no 
effect on the nuclear translocation of NF-kB in the presence of pVIII, suggesting that pVIII may 
not act to modulate IFN- promoter activity by targeting NF-kB and IRF7 transcriptional factors. 
Further experiments are needed to explore the possibility that pVIII interferes with the DNA 
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binding activity of IRF3 by assessing the function of CBP/p300 transcriptional co-activating 
proteins.   
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1 LITERCATURE REVIEW 
1.1 Adenovirus 
Adenoviruses are non-envelope virions, which were first isolated from adenoid tissue 
(Hilleman and Werner, 1954, Rowe et al., 1953). Adenoviruses contain an icosahedral capsid 
which encloses a double stranded linear DNA genome of variable size (26 to 45 kilobases) (Kovács 
et al., 2003). So far, more than 100 serotypes of adenoviruses have been identified affecting various 
vertebrate hosts (Babiuk and Tikoo, 2000), mostly associated with only mild clinical infections 
(Chiocca et al., 1996). Adenoviruses have been intensively studied for its molecular biology, which 
has contributed to the research of the splicing mechanism (Berget et al., 1977, Broker et al., 1977). 
Recently, intense studies have also focused on using adenoviruses as potential vectors for gene 
delivery (Babiuk and Tikoo, 2000, Nash and Parks, 2016, Toth et al., 2010). 
1.1.1 Adenovirus classification 
Adenoviruses belong to the family Adenoviridae and are classified into five genera 
including Mastadenovirus, Aviadenovirus, Ataadenovirus, Siadenovirus and Ichtadenovirus 
according to their host origins, phylogenetic relationships (Davison et al., 2003).  
Although members of Mastadenovirus and Aviadenovirus genuses only originate from 
mammals or birds respectively, members of Atadenovirus and Siadenovirus genuses have a wide 
variety of hosts. So far genus Ichtadenovirus has been reported to contain a single species 
confirmed in fish (Davison et al., 2003). 
Mastadenovirus is the largest genus, which is comprised of 25 adenovirus species infecting 
mammals (Knowles et al., 2012). They have been shown to infect human, bovine, monkeys, tree 
shrews, equine, murine, ovine, porcine, bats, canines. Human adenovirus (HAdV) is the first 
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member isolated in early 1950s from human adenoids (Rowe et al., 1953). So far 67 human 
adenovirus serotypes have been identified (Ghebremedhin, 2014, Rosen, 1960). The adenovirus 
genome is flanked by inverted terminal repeats (ITR) which also act as replication origin sites. The 
longest ITR is identified in bovine adenovirus (BAdV)-10 (Dán et al., 2001). Sixteen adenoviral 
genes shared by members of Mastadenovirus genus including DNA polymerase (pol), terminal 
protein (pTP), DNA binding protein(DBP), 52K, IVa2, pIIIa, III, pVII, pX, pVI, hexon, protease, 
100K, 33K, pVIII, fiber have been presumed to be inherited from a common ancestral. The 
proteins encoded by these genes function in DNA replication (pol, pTP, DBP), DNA encapsidation 
(52K and IVa2) and virion capsid formation (pIIIa, III, pVII, pX, pVI, hexon, protease, 100K, 
33K, pVIII, fiber) (Davison et al., 2003). However, capsid protein pIX, core protein pV and some 
of the protein products from E1, E3 and E4 regions are specific for members of Mastadenovirus 
genus (Davison et al., 2003).  
Members of Aviadenovirus genus only infect avian host, including chicken, falcon, goose, 
and turkey (Knowles et al., 2012) and contain genomes with the size of 43 to 45 kilobases encoding 
47 to 54 open reading frames (Chiocca et al., 1996, Griffin and Nagy, 2011, Kaján et al., 2012). 
Unlike Mastadenoviruses, the genes encoding pIX, pV, E2 region proteins, E3 region proteins are 
absent in Aviadenoviruses genomes (Davison et al., 2003, Grgić et al., 2011). Interestingly, two 
fiber proteins per vertex are present in Aviadenovirus virion, irrespective of the presence of one or 
two fiber genes in the virus genome (Griffin and Nagy, 2011, Marek et al., 2014). Compared to 
members of Mastadenovirus genus, the ITRs in the genomes of members of Aviadenovirus genus 
are at the same locations but relatively shorter. Some Aviadenoviruses including fowl adenovirus-
4, turkey adenovirus-3 and duck adenovirus-1 are associated with causing economically important 
diseases like hydropericardium syndrome (Brash et al., 2009, Pitcovski et al., 1998).        
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Atadenovirus genus is named because members of this genus contain high AT content in 
their genomes. Members of Atadenovirus genus can infect various hosts such as birds, reptiles, 
ruminant and marsupial (Benkö and Harrach, 1998, Benko et al., 2002, Hess et al., 1997). Their 
genomes have relatively smaller ITRs (46 to 118 bps) and don’t contain the genes encoding pV 
and pIX proteins (Benko et al., 2002, Vrati et al., 1995). However, members encode Atadenovirus 
genus-specific genes in E1 and E4 regions encoding proteins namely p32K and LH3 (ÉlŐ et al., 
2003, Gorman et al., 2005). 
Siadenovirus genus is named because members of the genus contain viral gene encoding 
sialidase. Members of Siadenovirus can infect reptiles, frogs and turkeys (Davison et al., 2003, 
Kovács and Benkő, 2009, Pitcovski et al., 1998). They have relatively short genomes with the size 
of about 26 kilobases containing short ITRs (Davison et al., 2003, Pitcovski et al., 1998). Similarly, 
the E1, E2, E3 and E4 early regions and the genes encoding proteins V and IX are absent in their 
genomes (Davison et al., 2003, Kovács and Benkő, 2009, Pitcovski et al., 1998). 
  Ichtadenovirus is the latest genus that has been reported in the Adenoviridae family 
(Davison et al., 2003). So far it has only one species, White Sturgeon Adenovirus 1 (WSAdV-1), 
which was isolated from white sturgeon (Davison et al., 2003). The genome of WSAdV-1 is 48,395 
bps, which is the longest genome identified in all known adenoviruses (Kovács et al., 2003).  
1.1.1.1 Virion structure of Adenoviruses family  
Adenoviruses are non-enveloped viruses with a double stranded linear DNA genome, 
which is surrounded by an icosahedral capsid (Gallaher and Berk, 2013, Kovács et al., 2003). The 
adenovirus capsid contains 13 proteins including major structural proteins (hexon, penton, fiber), 
minor structural proteins (IIIa, pVI, pVIII, pIX) and core proteins (pV, pVII, Mu, terminal protein, 
IVa2, adenovirus protease) (Fig 1.1). It is needed to mention that, the information below are based 
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on human adenovirus type 5(HAdV-5) since most of the current research on adenovirus are based 
on HAdV-5. 
For the major capsid proteins (hexon, penton, fiber), 720 copies of hexon are present at 
capsid facets as trimers per virion, 5 copies of penton are present at each of the 12 vertices, which 
makes a complex with a trimer of fiber (Russell, 2009). For the four minor capsid proteins (IIIa, 
pVI, pVIII, pIX), 240 copies of protein IX are present with C-terminus exposed outside of the 
capsid (Vellinga et al., 2005). 60 copies of protein IIIa are present at the inner capsid surface per 
virion. 360 copies of the protein VI are also present at the inner surface of capsid, which interact 
with protein IIIa, hexon, V (Matthews and Russell, 1998, Reddy and Nemerow, 2014, San Martín, 
2012, Vellinga et al., 2005). 120 copies of the protein VIII are present at the inner surface of capsid 
as well, provide a bridge between the major capsid protein hexon and the capsid (San Martín, 
2012). The core proteins (pV, pVII, Mu, terminal protein, IVa2, adenovirus protease) connect the 
capsid and the viral DNA genome to form the adenovirus core (Corden et al., 1976). Protein VII 
is associated with adenovirus genome (van Oostrum and Burnett, 1985). Protein Mu and V also 
function in connecting the capsid and core through their association with viral DNA 
genome.(Chatterjee et al., 1986, Hosokawa and Sung, 1976) . The terminal protein is found 
binding to the 5ʹ ends of viral DNA (Rekosh et al., 1977). Protein IVa2 present at only one vertex 
of the virion, involved in viral DNA encapsidation (Christensen et al., 2008, Ewing et al., 2007). 
Adenovirus protease has been reported to be involved in the cleavage of some virus-encoded 
precursor proteins for the virion maturation (Greber, 1998).                        
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Figure 1.1 Virion structure of Adenoviruses (Russell, 2009). 
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1.1.1.2 Genome organization  
             Adenovirus genome is divided into four early transcription regions (E1-E4), two 
intermediate genes (pIX and IVa2) and one major late unit which is alternatively spliced into five 
groups (L1-5) after transcription. DNA replication initiates from two DNA replication origin sites, 
namely inverted terminal repeats (ITRs). The viral genes are transcribed by RNA polymerase II 
(Mishoe et al., 1984) but the viral associated RNAs (VA RNAs) are reported to be transcribed by 
RNA polymerase III (Kidd et al., 1995). 
1.1.1.3 Adenovirius life cycle 
           The adenovirus life cycle can be divided into six steps: virus entry, expression of early 
genes, DNA replication, expression of intermediate genes, expression of late genes, virus assembly 
and release (Fig.1.2). 
The initial non-specific and electrostatic interactions between host cells and adenovirus 
have been observed, which help with the association between viral fiber protein and diverse 
cellular membrane receptors (Arnberg, 2009). After the initial attachment, virus internalization is 
triggered by the interaction between cellular surface integrins and arginine-glycine-aspartic acid 
(RGD) motif of viral penton protein (Shayakhmetov et al., 2005). The interaction activates 
phosphotidylinosito-3-OH kinase, which is involved in the rearrangement of actin cytoskeleton 
required for endocytosis (Varga et al., 1991). Moreover, the clathrin-mediated virus endocytosis 
also requires dynamin, GTPase, and the adaptor protein 2 for its regulation (Meier and Greber, 
2004).             
After virus internalization into the endosome, virus stimulates the endosome acidification 
and the partial uncoating of viral capsid proteins including penton, fiber, IIIa, hexon, VI, VIII, pIX 
(Gastaldelli et al., 2008, Greber et al., 1993), the lytic portion of pVI gets exposed after 
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Figure 1.2 Adenovirus life cycle (Waye and Sing, 2010) 
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cleavage by adenovirus protease, leading to the disruption of endosomal membrane and 
transportation of virus into the microtubule organization center (MTOC) located near the nucleus 
by using the microtubule motor protein dynein in cytoplasm (Bremner et al., 2009, Kelkar et al., 
2006, Wiethoff et al., 2005). The virus attaches to the nuclear pore complex (NPC) through the 
association between virus hexon protein with cytoplasmic nucleoporins (Nups) Nup214 and 
Nup358 which are located in fibrils on NPC (Cassany et al., 2015, Leopold et al., 2000). In 
addition, molecular motor kinensin 1 has been reported to be required for further virus uncoating 
at the NPC. Finally, the cellular transportation factors such as transportin, importin and histone H1 
are required for the transportation of viral DNA genome complex into the nucleus through NPC 
(Hindley et al., 2007, Strunze et al., 2011, Wodrich et al., 2006). The expression of the early genes 
first starts with the transcription of E1A region, which produces two main E1A proteins namely 
289R and 243R with various functions including the induction of S phase in the infected cells, 
control of cell cycle and the transcription of other early genes  (Avvakumov et al., 2002). 
The E1B region encodes two proteins, namely E1B-55K and E1B-19K, both have 
functions in apoptosis prevention. The E1B-19K has been shown to inhibit the programmed cell 
death by suppressing the activity of the pro-apoptotic proteins BAK and BAX (Sundararajan et al., 
2001). The E1B-55K together with viral protein E4orf6 and some cellular proteins has been 
reported to block tumor suppressor p53 protein-dependent apoptosis by causing the p53 
degradation (Sarnow et al., 1984). The E2 region encodes three proteins:  DNA binding protein 
(DBP), DNA polymerase (Pol) and pre-terminal protein (pTP), involved in viral DNA replication 
(de Jong et al., 2003). DNA binding protein has been shown to be involved in the binding of viral 
DNA polymerase to the DNA genome, the unwinding of viral double-stranded DNA and the 
removal of the secondary structures during the elongation of DNA replication (Dekker et al., 1997, 
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van Breukelen et al., 2003). The transcription of E3 region is regulated by promoter responsive to 
E1A and produces four proteins, namely E3-19K, 10.4K, 14.5K and 14.7K, which are involved in 
the evasion of host immune defense (Horwitz, 2004) (described in details in section 1.2.4). The E4 
region encodes six proteins, namely orf1, orf2, orf3, orf4, orf6 and orf7, which are involved in the 
control of cell cycle, regulation of the viral DNA replication, the expression of late viral proteins 
and counteraction of the antiviral innate immune response (Greer et al., 2011, O'Shea et al., 2005, 
Ullman and Hearing, 2008, Weitzman and Ornelles, 2005). For example, E4orf3 and E4orf6 have 
been shown to increase the expression of late viral genes by contributing to the cytoplasmic 
accumulation and stability of viral mRNA (Imperiale et al., 1995).  
Adenovirus DNA replication starts after accumulation of the E2 gene products (DBP, DNA 
Pol and pTP). The inverted terminal repeats (ITRs) which locate at both ends of viral DNA genome 
are two origin sites of DNA replication (Hay, 1985). The pre-terminal protein (pTP) binding to the 
5ʹ end of DNA works as a protein primer to initiate the viral DNA replication (de Jong et al., 2003). 
Moreover, the pre-initiation complex (PIC) comprised of all E2 gene products (pTP, Pol and DBP) 
and two cellular proteins, namely nuclear factor I (NFI) and NFIII is also required for the 
replication initiation (Bosher et al., 1990, Hoeben and Uil, 2013, Mul et al., 1990). Virus-encoded 
DNA polymerase has both 5’ to 3’ polymerase activity and 3’ to 5’ exonuclease activity. The 
nuclear factor NFII and E2 gene products (Pol and DBP) have been shown to be required for the 
replication elongation (Challberg et al., 1980, Lichy et al., 1981, Nagata et al., 1983). During the 
initiation of viral DNA replication, two intermediate proteins IVa2 and pIX are also produced. 
Protein IVa2 has been reported to be involved in the regulation of major late promoter (MLP) 
activity, viral capsid formation and DNA encapsidation (Lutz and Kedinger, 1996, Tribouley et 
al., 1994, Zhang and Imperiale, 2003). Protein IX is a minor structural protein with various 
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functions including the stabilization of viral capsid and activation of major late promoter (MLP) 
(Boulanger et al., 1979, Lutz et al., 1997). Moreover, it has been recently studied as a target for 
the alteration of adenovirus tropism by addition of other ligands (Dmitriev et al., 2002). 
Late (L) genes are expressed after the initiation of DNA replication. All late genes are 
encoded by a major late transcription unit (MLTU) to produce a single pre-mRNA, which is 
subsequently spliced and polyadenylated with differential poly A sites into approximate 20 mature 
late mRNAs (Fraser et al., 1979, Nevins and Darnell, 1978). In HAdV-5, the mature late mRNAs 
are divided into five groups (L1-L5) according to the use of poly A sites (Nevins and Darnell, 
1978, Ziff and Evans, 1978). They are expressed under the regulation by major late promoter 
(MLP), which has very low activity during the early infection but gets stimulated by viral proteins 
IVa2 and L4-22k during the late phase of infection (Backström et al., 2010, Pardo-Mateos and 
Young, 2004, Tribouley et al., 1994).  
Virus assembly starts in the cytoplasm where protein hexon forms the trimer with the 
assistance of L4-100K protein (Horwitz et al., 1969, Velicer and Ginsberg, 1970). Transport of 
hexon trimmers along with other proteins including penton to nucleus leads to the formation of the 
empty capsids in the nucleus of infected cells (Cepko and Sharp, 1982). Then, adenovirus DNA 
genome is packaged into the empty capsids starting with the left end of genome which contains 
seven AT-rich repeat elements (A1-A7) necessary for adenovirus DNA encapsidation (Edvardsson 
et al., 1976, Hammarskjöld and Winberg, 1980, Hearing et al., 1987, Ostapchuk and Hearing, 
2003). Moreover, protein IVa2 has also been shown to be involved through the interaction with 
DNA packaging sequence. Finally, some structural proteins are cleavaged by viral protease for the 
maturation of infectious virus progeny (Mangel et al., 2003, Weber, 1976). Although virus 
particles have been found to be released from the infected cells about 30 hrs post-infection, the 
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exact mechanism for adenovirus release is unknown. Viral E3-11.6kDa protein has been suggested 
to be involved in the lysis of infected cells (Tollefson et al., 1996). 
1.1.2 Bovine adenovirus 
The isolation of Bovine adenovirus (BAdV) was first reported in 1959 from cattle 
respiratory secretion (Klein et al., 1959). To date, fourteen different serotypes of bovine 
adenoviruses mostly associated with only mild-clinical infections have been identified from both 
cattle samples and environment (Lehmkuhl et al., 1975, Lehmkuhl and Hobbs, 2008, Sibley et al., 
2011). 
1.1.2.1 Classification of Bovine adenoviruses  
Based on the phylogenetic proximit, the currently known fourteen serotypes of bovine 
adenovirus can be divided into six groups (A-F). Based on various criteria including nucleotide 
content, genus specific antigens and restriction enzyme analysis pattern, bovine adenovirus 
serotypes are classified in Mastadenovirus and Atadenovirus genuses.  
1.1.2.2 Characteristics of BAdV-3 
Bovine adenovirus 3 (BAdV-3) is a non-enveloped virus with an icosahedral capsid of 75 
nm diameter, which wraps a double-stranded linear DNA genome with size of 34,446 base pairs 
(Reddy et al., 1999). The isolation of BAdV-3 was first reported in 1965 from the conjunctiva of 
a healthy cattle (Darbyshire et al., 1965). Recently, isolation of BAdV-3 from sick calves was also 
reported in China (Zhu et al., 2011).  
1.1.2.3 Genome organization of BAdV-3 
BAdV-3 has a linear double-stranded DNA genome of 34,446 base pairs, with a G+C 
content of 54%, which is close to G+C content reported for genomes of HAdV-2, HAdV-5 and 
HAdV-12 (Chroboczek et al., 1992, Reddy et al., 1999, Sprengel et al., 1994). Like other 
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Mastadenoviruses, the genome of BAdV-3 is also divided into early regions, intermediate regions 
and late regions (Fig. 1.3) (Reddy et al., 1998). Unlike other Mastadenoviruses, the DNA 
packaging sequence of BAdV-3, which is present at the left end of genome also contains a part of 
E1A region, in addition, the E1A promoter of BAdV-3 has been reported to present in the left ITR 
region (Xing and Tikoo, 2006). Unlike HAdV-5 late genes, the late genes of BAdV-3 genome are 
divided into 7 families (Chroboczek et al., 1992, Xing and Tikoo, 2006).  
1.1.2.3.1 Early genes  
The E1 region of BAdV-3 is divided into two parts, namely E1A and E1B (Berk and Sharp, 
1978, Reddy et al., 1998, van Olphen and Mittal, 2002). Unlike HAdV-5, the inverted terminal 
repeats (ITRs) contain E1A sequence promoter as BAdV-3 (containing deletion of the sequence 
between the left ITR and the ATG of the E1A protein) retains replication-competence (Xing and 
Tikoo, 2006).The E1A region is the first to be transcribed at 12-36 hrs post infection in infected 
cells, producing three relatively small proteins (211, 115 and 100 amino acids) by alternatively 
spliced mRNAs with the same N-terminus (Reddy et al., 1998). Like HAdV-5, the E1A proteins 
of BAdV-3 are non-structural proteins, which are crucial for BAdV-3 replication and 
transactivation of other viral genes (Reddy et al., 1998, Zheng et al., 1994, Zhou and Tikoo, 2001). 
The E1B region produces two proteins (157 and 420 amino acids) at 6-48 hours post infection by 
two overlapping mRNAs with the same N-terminus, which have been shown important for the 
BAdV-3 replication (Zhou and Tikoo, 2001). The BAdV-3 E2 region is divided into E2A and E2B, 
which produces proteins required for virus replication(Reddy et al., 1998). 
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Figure 1.3 Schematic representation of Bovine adenovirus 3 genome (Reddy et al., 1998). 
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The E2A region encodes DNA binding protein (DBP), which shows 18 to 47% amino acid 
sequence identities with other Mastadenovirus DBPs (Chase and Williams, 1986, Reddy et al., 
1998). The DBP of BAdV-3 contains a variable N-terminus, which has been shown to determine 
the host range, and a highly conserved carboxy-terminal region which has been shown to be 
involved in DNA binding, activation of the major late promoter and virus replication (Anderson 
and Klessig, 1984, Kitchingman, 1985, Tucker et al., 1994). In addition, motifs with basic amino 
acid in BAdV-3 DNA binding protein, for example 29PRKK32, 35RKRR38, and 53KRAK56, have 
the potential to act as nuclear localization signals (NLS) for the transportation of DBP into the 
nucleus (Reddy et al., 1998). The E2B region produces two proteins, namely DNA polymerase 
and precursor terminal protein (pTP) with 59-60% and 58-60% amino acid identities with similar 
proteins encoded by other members Mastadenovirus genus. (Baxi et al., 1998, Reddy et al., 1998). 
Moreover, YSRLVYR motif in BAdV-3 precursor terminal protein has been shown to be essential 
to function as primer for the initiation of viral DNA replication (Baxi et al., 1998). However, unlike 
HAdV-2 pTP, two potential protease cleavage sites have been identified in BAdV-3 precursor 
terminal protein (Baxi et al., 1998, Webster et al., 1994). 
The BAdV-3 E3 encodes four proteins (284, 121, 86 and 82 amino acids) by spliced 
mRNAs. Although E3 is not essential for viral replication (Zakhartchouk et al., 1998), it has been 
speculated to influence the adenovirus pathogenesis (Idamakanti et al., 1999, Morin et al., 1987, 
Reddy et al., 1998). The 284R protein is a glycoprotein, which has been found to be exclusive to 
BAdV-3 without any sequence identities to E3 proteins of HAdV-2 (Idamakanti et al., 1999). Like 
HAdV-5 14.7K, the 121R protein has been found to inhibit the tumor necrosis factor (TNF)-α 
mediated apoptosis (Gooding et al., 1988, Mittal et al., 1992, Zakhartchouk et al., 2001). 
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The E4 region, located at the right end of BAdV-3 genome (Bridge and Ketner, 1989, 
Reddy et al., 1998) encodes five potential proteins (ORF 1-5) encoded by alternatively spliced 
mRNAs (Baxi et al., 2001, Reddy et al., 1998). Although BAdV-3 E4ORF3 and E4ORF5 show 
limited homology with HAdV-5 E4orf6 protein, BAdV-3 E4ORF 1, E4ORF2 and E4ORF4 show 
no amino acid sequence identities with corresponding Orfs encoded by HAdV-5 E4 mRNAs (Baxi 
et al., 2001, Bridge and Ketner, 1989). 
Two copies of non-coding RNAs, namely viral associated (VA) RNAs have been reported 
in HAdV-2, they are transcribed by genes mapped between the 52/55K and pTP encoding genes 
and RNA polymerase III (Ma and Mathews, 1996, Reich et al., 1966). Various functions including 
antagonism of the host defense response has been identified for VA RNAs (Kitajewski et al., 1986, 
O'Malley et al., 1986, Sano et al., 2006). However, no VA RNAs have been reported in BAdV-3 
so far.  
1.1.2.3.2 Intermediate genes 
Like HAdV-5, two intermediate proteins IVa2 and IX are produced by BAdV-3(van 
Oostrum and Burnett, 1985) .The protein IVa2 is a structural protein (376 amino acids), which 
shares 29 to 69% sequence identity with other IVa2 proteins encoded by adenoviruses (Reddy et 
al., 1998). The protein IX is a minor structural protein (125 amino acids), which shares 16-28% 
sequence identity with pIX encoded by other members of Mastadenovirus (Reddy et al., 1998, 
Zheng et al., 1999). Like HAdV-5, the C-terminal portion of BAdV-3 protein IX has been found 
to be exposed outside of the viral capsid (Ayalew et al., 2015, Zakhartchouk et al., 2004). Protein 
pIX has been exploited as a potential target to alter viral tropism by insertion of other targeting 
ligands. The fiber-independent tropism of BAdV-3 has been enhanced by the integration of RGD 
motif at C-terminus of protein IX. This has the potential to improve the delivery efficiency of 
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BAdV-3 vectored vaccine and the host range of targets (Ayalew et al., 2015, Zakhartchouk et al., 
2004).  
1.1.2.3.3 Late genes  
Unlike HAdVs that have five families (L1-L5) of late mRNAs, the major late transcription 
unit (MLTU) of BAdV-3 is divided into seven late regions (L1-L7) according to the use of 
polyadenylation sites (Fraser et al., 1982, Reddy et al., 1998).  
The BAdV-3 L1 region encodes for four proteins namely 52K, IIIA, III and VII, which 
share the same polyadenylation site in the mRNAs (Kreivi et al., 1991, Reddy et al., 1998). BAdV-
3 protein 52K is a non-structural protein (331 amino acids), which shares 21.4 to 61.6% identity 
with 52K proteins encoded by other adenoviruses (Reddy et al., 1998). BAdV-3 protein 52K is 
expressed as a 40 kDa protein both in transfected and infected cells, and predominantly localizes 
in the nucleus (Paterson et al., 2012). The three residues 105RKR107 of the identified nuclear 
localization signal (amino acids 102 to 110) have been shown to be crucial for BAdV-3 52K 
nuclear transportation (Paterson et al., 2012). The cellular nuclear import receptor importin α3 of 
the classical importin α/β-dependent pathway is utilized by 52K protein for nuclear transport 
(Paterson et al., 2012). Protein 52K has been shown to interact and redistribute the cellular protein 
NFκB-binding protein (involved in the ribosomal RNA processing) from the nucleolus to the other 
parts of nucleus (Paterson et al., 2012, Paterson, 2010). Moreover, BAdV-3 52K has also been 
shown to be interact with BAdV-3 protein pVII (Paterson et al., 2012).  
BAdV-3 protein IIIa is a structural protein (568 amino acids) shows25 to 75% identity with 
IIIa proteins encoded by other adenoviruses (Reddy et al., 1998). BAdV-3 IIIa contains a potential 
viral protease cleavage site at 19 amino acids from the C-terminus. The adenovirus IIIa protein has 
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been shown to be involved in the capsid stabilization by connecting the hexon trimmers (Vellinga 
et al., 2005).  
BAdV-3 protein III shows 44% to 64% identity with penton proteins encoded by other 
adenoviruses (Reddy et al., 1998). Like HAdVs (Caillet-Boudin, 1989; Zubieta et al., 2005), BAdV-
3 protein III is also predicted to be involved in virus internalization through interaction with fiber 
protein. However, unlike HAdV-5, BAdV-3 protein III doesn’t contain the integrin binding motif - 
tripeptide Arg-Gly-Asp (RGD) motif, which is required for the viral endocytosis during virus 
internalization (Neumann et al., 1988, Reddy et al., 1998). 
BAdV-3 protein VII is a core protein with 29.7 to 53.2% identity with protein VII encoded 
by other adenoviruses. A potential viral protease cleavage site has been suggested at location 
adjacent to the N-terminus (Reddy et al., 1998). Moreover, a mitochondria (MLS) localization signal 
has been identified in BAdV-3 protein VII (amino acid 1-54) which directs the mitochondria 
localization of protein VII leading to the modulation of mitochondrial Ca2+ and ATP production, 
and inhibition of apoptosis (Anand et al., 2014).  
The BAdV-3 L2 region encodes only protein V (423 amino acids), which shows 28 to 40% 
identity with protein V encoded by other members of Mastadenovirus genus (Reddy et al., 1998).  
Protein V is detected as a 55kDa protein within transfected or BAdV-3 infected cells (Zhao and 
Tikoo, 2016) and appears essential for efficient viral replication (Zhao and Tikoo, 2016). Protein 
V uses three nuclear localization signal (amino acids 80-120, 190-210 and 380-389) and two 
nucleolar localization signals  (amino acids 21-50 and 380-389) to locate in the nucleus and 
nucleolus, respectively of  BAdV-3 infected cells, and the nucleolar signals appear essential for 
replication of BAdV-3 (Zhao and Tikoo, 2016). In addition, protein V interacts with 33K protein 
(Kulshreshtha and Tikoo, 2008).  
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The L3 region of BAdV-3 encodes protein X with38 to 64% identity with the pX encoded 
by other adenoviruses (Reddy et al., 1998). Amino acid sequence analysis have identified a 
potential bipartite nuclear localization signal and two potential protease cleavage sites 
(27LRGG↓S31) and (47LRGG↓F51) in BAdV-3 protein X (Reddy et al., 1998, Russell and Kemp, 
1995, Weber, 1995). 
The L4 region of BAdV-3 encodes protein VI (263 amino acids), a structural protein, which 
shares 15 to 38% identity with other adenoviruses (Reddy et al., 1998). Analysis of amino acid 
sequence of BAdV-3 protein VI identified two potential viral protease cleavage sites at both the 
N-and C-terminus (Reddy et al., 1998, Russell and Kemp, 1995). Moreover, protein VI has been 
postulated to be a cofactor for the function of adenoviral protease and mediate the endosome 
membrane disruption (Honkavuori et al., 2004, Kauffman and Ginsberg, 1976, Reddy et al., 1998). 
The BAdV-3 L5 region encodes two proteins hexon and protease (Reddy et al., 1998). 
BAdV-3 protein hexon is a major capsid protein (910 amino acids), which shows 45 to 70% amino 
acid sequence identity with hexon proteins encoded by other adenoviruses (Reddy et al., 1998). It 
is expressed as 98kDa protein in BAdV-3 infected cells (Kulshreshtha et al., 2004). BAdV-3 
protease shows 30 to 65% amino acid identity with proteases encoded by other adenoviruses 
(Reddy et al., 1998). During BAdV-3 infection, the precursors of structural proteins pIIIa, pVI, 
pVII, pVIII, pX, and pTP supposed to be cleaved by viral protease, which is essential for the 
production of infectious virion (Reddy et al., 1998).  
The BAdV-3 L6 region encodes three non-structural proteins 100K, 33K and 22K, and one 
structural protein pVIII (Reddy et al., 1998). The BAdV-3 100K protein shows 27 to 52% amino 
acid sequence identity with 100K protein encoded by other adenoviruses (Reddy et al., 1998). 
BAdV-3 100K protein is expressed as 130 kDa protein in infected cells and localizes to the 
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cytoplasm and the nucleus (Makadiya et al., 2015). It has been reported that cleavage of 100K by 
adenoviral protease is required for nuclear localization in infected cells but not for BAdV-3 
replication (Makadiya et al., 2015). Interestingly, although C-terminus of full length 100K contains 
bi-partite nuclear localization signal, only cleaved C-terminal 100K containing bipartite NLS 
localizes to nucleus by interacting with importin 3 (Makadiya et al., 2015). In addition, BAdV-3 
100K interacts with another non-structural protein 33K (Kulshreshtha and Tikoo, 2008). BAdV-3 
33K and 22K proteins, produced from a single transcript by alternative splicing, contain the same 
N-terminal portion of 138 amino acids but different C-terminal portions (Kulshreshtha et al., 2015). 
BAdV-3 33K is expressed as five proteins of 42 kDa, 39 kDa, 37 kDa, 21 kDa and 19 kDa in 
infected cells, which localize to nucleus by interacting with importin-α5 import receptor of 
classical / nuclear transport pathway and transportin-3 import receptor of transportin pathway 
(Kulshreshtha et al., 2014). The C-terminus conserved residues (201-240 amino acids) of BAdV-
3 33K are required for the activation of major late promoter (Kulshrestha et al., 2015). Moreover, 
leucine residues at 217, 224, 232 and 240 appear required for the binding of 33K protein to major 
late promoter of BAdV-3 (Kulshrestha et al., 2015). BAdV-3 33K bind to 100K protein and protein 
V in infected cells (Kulshreshtha and Tikoo, 2008) 
BAdV-3 22K is expressed as 42kDa and 37 kDa proteins in infected cells and 42kDa 
protein in transfected cells, it appears to be essential for virus replication (Kulshreshtha et al., 
2004). Unlike 33K, 22K does not appear to stimulate the transcription from major late promoter 
(Kulshrestha et al., 2015). 
BAdV-3 protein VIII is a structural protein (216 amino acids), which shows 19 to 56% 
amino acid identity with protein VIII encoded by other adenoviruses (Reddy et al., 1998, 
Sussenbach, 1984). While protein VIII is expressed as 8 kDa and 24 kDa proteins in infected cells, 
20 
 
only 8 kDa protein could be detected in purified mature virion (Ayalew et al., 2014). Protein VIII 
localizes to the nucleus in infected cells by interacting with importin 3 (Ayalew et al., 2014). 
Interaction between BAdV-3 pVIII and cellular protein DEAD box (DDX) 3 abrogates the 
translation of capped mRNA at late times post infection (Ayalew et al., 2014). Moreover, two 
potential viral protease cleavage sites (108IAGG↓G112, 143LGGG↓S147) have been reported in 
pVIII, which appear necessary for the BAdV-3 replication (Gaba et al., 2017). 
The BAdV-3 L7 region encodes protein named fiber with 17% to 26% amino acid sequence 
identity with fiber proteins encoded by other adenoviruses (Reddy et al., 1998). The knob region 
of BAdV-3 fiber has been suggested to be involved in the initial interaction with cellular receptor 
during BAdV-3 infection (Bangari et al., 2005). A conserved FNLVYPYKA motif has been found 
in the tail region, which is suggested to interact with viral penton protein (Caillet-Boudin, 1989, 
Reddy et al., 1998). In addition, a nuclear localization signal at the amino acids 14 to 20 has been 
identified in BAdV-3 fiber protein, which appears essential for efficient virus replication (Wu and 
Tikoo, 2004). 
1.2 Innate immune system and virus evasion strategies 
The innate immune system provides host cells the first line of protection from pathogen 
infections. Among all the sensing strategies utilized by host innate immune system of viral 
components known as pathogen-associated molecular patterns, the fundamental mechanisms 
based on pattern recognition receptors (PRRs) are well characterized.   
1.2.1 Pattern recognition receptors and Pathogen-associated Molecular Patterns 
Based on the protein domain homology, the pattern recognition receptors (PRRs) can be 
divided into several classes including Toll-Like Receptors (TLRs) and the C-type lectin receptors 
(CLRs) that are transmembrane proteins expressed at the cell surface or in endocytic 
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compartments; retinoic acid inducible gene-I (RIG-I)-like receptors (RLRs), nucleotide 
oligomerization and binding domain (NOD)-like receptors (NLRs), the AIM2-like receptors 
(ALRs) that are intracellular receptors expressed in cytosol or within endosomes (Jang et al., 2015, 
Kumar et al., 2011). 
Toll-Like Receptors (TLRs), first identified in Drosophila are the best-characterized PRRs 
(Lemaitre et al., 1996). While, eleven functional TLRs have been reported in mice, namely TLR 
1-7, TLR 9 and TLR 11-13, ten TLRs have been found in human, known as TLR 1-10 (Akira and 
Takeda, 2004, Takeda et al., 2003). Most TLRs are expressed by immune cells such as dendritic 
cells and macrophages (Kawai and Akira, 2009). The TLRs (3, 7, 8 and 9) that recognize viruses 
located in endosomal membrane and get to sense viral RNA or DNA nucleic acids after virus 
endocytosis. For example, TLR3 has been found to be activated by dsRNA, TLR7 by ssRNA and 
TLR 9 by unmethylated CpG-DNA motifs (Shayakhmetov et al., 2010). In addition, TLR3 is 
expressed in most cell types while TLR7 and TLR9 are mainly expressed in plasmacytoid dentritic 
cells (Colonna et al., 2004). After synthesis of these TLRs in endoplasmic reticulum (ER), the ER 
membrane protein UNC-93B transport TLRs into the endosome (Brinkmann et al., 2007, Tabeta 
et al., 2006). After the transportation into the endosomal compartment, these TLRs require 
proteolytic processing by endosomal proteases to be competent to recruit adaptors and bind to viral 
ligands. For example, studies have suggested that the ectodomains of TLR9, TLR3 and 7 are 
cleaved by cathepsins (Ewald et al., 2008, Park et al., 2008). Moreover, the proteolytic processing 
of these TLRs in endolysosome has also been shown to avoid the aberrant activation of TLRs such 
as upon the recognition of self DNA (Diebold and Brencicova, 2013, Kawai and Akira, 2010). All 
TLRs are type I transmembrane proteins that consist of ectodomains with leucine-rich repeats 
which mediate PAMP recognition, transmembrane domains which help in receptor localization on 
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cell surface or in endosomes primarily and, cytoplasmic Toll-interleukin-1 receptor homology 
(TIR) domains, which bind to adaptor proteins and transfer downstream signaling (Akira and 
Takeda, 2004). The TLRs engage various adaptors located at the cell surface or in the endosomal 
compartments for downstream signaling cascade, including the TIR-containing adaptor protein 
(TIRAP), the TRIF-related adaptor molecule (TRAM), the TIR domain–containing adaptor-
inducing IFN-β (TRIF), and the protein myeloid differentiation primary response 88 (MyD88).  
Most TLRs utilize MyD88 adapter except for TLR3, which only uses TRIF adapter. Moreover, 
TLR4 is unique in that it utilizes both MyD88 and TRIF adaptors sequentially (Feng and Chao, 
2011, Takeda and Akira, 2005, Yamamoto et al., 2002). Stimulation of TLRs after the recognition 
of virus infection activates complex signaling cascades that a) lead to the synthesis of pro-
inflammatory cytokines, antiviral cytokines and type I IFNs (Thompson and Iwasaki, 2008), b) 
result in the activation of the mitogen-activated protein kinases (MAPKs), which can induce the 
expression of various genes that regulate the inflammatory response (Arthur and Ley, 2013) and 
may c) lead to the induction of adaptive response after the recognition by dendritic cells, which 
are the most potent antigen-presenting cells (Iwasaki and Medzhitov, 2004). 
 In addition to TLRs, C-type lectin receptors (CLRs) are also transmembrane receptors, 
which are expressed on the plasma membrane (Areschoug and Gordon, 2008). Langerin has been 
reported to be competent to clear HIV in Birbeck granules through endocytosis and degradation 
(de Witte et al., 2007). Dectin-1 and DC-SIGN are involved in anti-fungal defense (Den Dunnen 
et al., 2009).  
The RIG-I-like receptors (RLR) are expressed by most cell types and constitute a family 
of cytoplasmic RNA helicases including retinoic acid-inducible gene-I (RIG-I), melanoma 
differentiation-associated gene 5 (MDA5), and Laboratory of Genetics and Physiology 2(LGP2, 
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also known as DHX58) (Yoneyama et al., 2004). Both RIG-I and MDA5 have been found to 
recognize viral RNA through the utilization of a common adaptor localized at the mitochondrial 
membrane named mitochondria antiviral signaling protein (MAVS), which activates two protein 
kinase complexes: complex 1 consists of TANK (TRAF family member associated NF-κB 
activator), TBK1 (TANK-binding kinase 1), TRAF3 (TNF receptor associated factor 3) and IKKε 
(inhibitor of κB kinase ε); complex 2 consists of RIP1 (receptor interacting protein), TRAF-6, 
TAK1 (TGF-β activated kinase 1), IKKα and IKKβ and  NEMO (NF-κB essential modulator) 
(Seth et al., 2005), which results  in the induction of antiviral cytokines and type I interferons  
expression (Kawai et al., 2005, Meylan et al., 2005, Seth et al., 2005). Two caspase activation and 
recruitment domains (CARDs) have been reported in N-terminus of both RIG-I and MDA5, which 
initiate downstream signaling and facilitate a structure realignment after getting exposed. 
Moreover, RIG-I has a C-terminal regulatory domain (RD), which confers RIG-I an auto-inhibited 
state (Saito et al., 2007, Yoneyama and Fujita, 2008).  Despite the similar structural domains shared 
by RLRs, they have significant differences in activation mechanisms and preferences for 
recognizing viral ligands (Gack et al., 2007).  
 RIG-I recognizes single-stranded (ssRNA) with 5' triphosphate end, and also double-
stranded (dsRNA) without terminal triphosphates with a preference for short dsRNA. RIG-I 
detects blunt, short, double-stranded 5'-triphosphate RNA discriminatingly, which is common in 
the panhandle region of ssRNA viral genomes (Hornung et al., 2006, Kato et al., 2008). Longer 
dsRNA (over 1kb) are preferably recognized by MDA5 compared to those recognized by RIG-I 
(Kato et al., 2008). Based on different preferences on viral ligands recognition, RIG-I and MDA5 
function as critical PRR for different viruses. While RIG-I has been found engaged by Sendai virus 
(SeV), vesicular stomatitis virus (VSV), influenza, hepatitis C virus, Japanese encephalitis virus 
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and small RNA encoded by the DNA virus Epstein-Barr virus (Kato et al., 2006, Saito et al., 2007, 
Yoneyama and Fujita, 2008), MDA5 has been found to induce innate immunity in picorna viruses 
(Gitlin et al., 2006).  
Laboratory of genetics and physiology 2 (LGP2) protein, which has similar helicase 
domain as RIG-I and MDA5 has been suggested to act as both positive and negative regulator of 
RIG-I and MDA5 depending on the type of virus infection (Yoneyama et al., 2005). For example, 
studies have shown that while lgp2 knockout in mice can augment type I IFN induction following 
poly I:C transfection or VSV infection, LGP2 is required for the induction of antiviral response 
during EMCV infection (Komuro and Horvath, 2006, Venkataraman et al., 2007). However, the 
underlying mechanisms of these LPG2 conflicting functions are unclear. 
NOD like receptors (NLRs) consist of a large family of 22 members identified in human 
that recognize various PAMPs and stress signals (Martnon et al., 2009). They comprise multiple 
domains including a C-terminal leucine-rich repeat (LRR) domain responsible for detecting 
PAMPs and danger associated molecular patterns (DAMPs) leading to the activation of NLRs, a 
central nucleotide oligomerization and binding domain (NOD) domain and a N-terminal effector 
domain. Depending on the N-terminal domains, the NLRs can be divided into three groups: pyrin 
domain (PYD)-containing subfamily (NLRPs) and CARD-containing subfamily (NOD1, NOD2, 
NLRCs, CIITA) which have been shown involved in the regulation of the antiviral innate 
immunity, and baculovirus inhibitor repeat (BIR) domain-containing subgroups (Ting et al., 2008).  
Moreover, some NLRPs such as NLRP1, NLRP2, NLRP3 and NLRP6 show an important role in 
the inflammatory response by forming an inflammasome complex and leading to the activation of 
caspase-1, which leads to the proteolytic activation of the pre-formed pro-inflammatory cytokines 
IL-1ß and IL-18 (Elinav et al., 2011, Keller et al., 2008, Martinon et al., 2002). For example, 
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NLRP3, also known as NALP3, forms an ASC (Apoptosis–associated speck-like protein 
containing a caspase recruitment domain)–dependent inflammasome complex after sensing stimuli 
including bacterial or viral infections, cellular stress such as membrane disruption and ATP or uric 
acid released from damaged/dying cells (Martnon et al., 2009). Studies have shown that Sendai 
virus, influenza virus and adenovirus can activate the NLRP3-ASC-caspase-1 inflammasome 
(Kanneganti et al., 2006, Muruve et al., 2008). However, poly I:C transfection has been found not 
able to induce inflammasome activation, which suggests that viral RNAs alone are insufficient for 
inflammasome activation (Jacobs and Damania, 2012). In addition, some NLRPs have shown 
negative effect on immune response. For example, NLRP4 has been shown to downregulate type 
I IFN response through the degradation of TBK1 (Cui et al., 2012). 
In addition, more cytosolic DNA sensors have been elucidated recently. For example, 
DNA-dependent activator of IFN-regulatory factors (DAI) has been found to bind to cytosolic 
dsDNA and lead to the production of type I IFNs through the TBK1-IRF3 signaling (Takaoka et 
al., 2007). The DNA sensor IFI16, which belongs to a protein family named the pyrin and HIN 
domain (PYHIN) family has been found to recruit an adaptor named STING (The endoplasmic 
reticulum (ER)-resident transmembrane protein stimulator of IFN genes) to activate 
IFNβ induction by TBK1-IRF3 signaling (Burdette et al., 2011, Tsuchida et al., 2010). The 
helicase DDX41 has also been identified to be involved in DNA sensing through the engagement 
of STING (Zhang et al., 2011). AIM2 (absent in melanoma 2) is another member of the PYHIN 
family, which can trigger the formation of inflammasome upon activation and result in the 
production of mature IL-1β and IL-18 (Jones et al., 2010). p202 is another member of the PYHIN 
family which has shown to repress caspase-1 activation in contrast to AIM2 (Roberts et al., 2009). 
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1.2.2 Type I Interferon response induced antiviral state 
The detection of the pathogen-associated molecular patterns (PAMPs) by pattern 
recognition receptors (PRRs) will activate the transcriptional innate immune responses by different 
signaling pathways particularly the production of type I interferons (IFNs). These IFNs in turn 
induce a battery of genes that directly suppress viral replication (Brubaker et al., 2015). The PRR-
mediated recognition has also been shown to activate non-transcriptional responses such as 
phagocytosis, autophagy and cell death (Deretic et al., 2013, Lamkanfi and Dixit, 2014). The type 
I Interferon response can also direct the activation of the adaptive immune response, which is more 
antigen-specific and long-lasting (Palm and Medzhitov, 2009). 
Interferons, discovered in 1957 in chicken, were the first cytokines to be described. They 
are named because of the ability to interfere with viral replication (Isaacs and Lindenmann, 1957). 
Interferons are divided into three groups namely type I, II, III IFNs (Randall and Goodbourn, 
2008). Type I IFNs identified in humans include twelve IFN-α subtypes, one IFN-β and multiple 
less-known ones such as IFN-ω, IFN-δ, IFN-ε, IFN-τ and IFN-κ (Hardy et al., 2004). IFN-α 
subtypes are mostly induced by plasmacytoid dendritic cells (pDCs), but IFN-β can be produced 
by most cell types (Hardy et al., 2004). Type II IFN also named IFN-γ, was first identified  in 
human leukocytes has also been detected in activated immune cells including T cells, NK cells, B 
cells and NKT cells (Wheelock, 1965; Schroder et al., 2004). Type III IFNs comprising of  four 
subtypes (IFN-λ (IFN-λ1, IFN-λ2, IFN-λ3, IFN-λ4). have been detected primarily  in plasmacytoid 
dendritic cells and epithelial cells (Kotenko, 2002, Kotenko et al., 2003, Sheppard et al., 2003, 
Sommereyns et al., 2008). 
Type I IFNs have been shown to be significant for the induction of innate immunity and 
regulation of the adaptive immune response (Stetson and Medzhitov, 2006). Recognition of viral 
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components by PRRs triggers the activation and induction of IFNs (described in Section 1.2.1). 
The activated PRRs initiate various signaling, which result in the activation of transcription factors 
named IRF-3, IRF-7, AP-1 and NFκB by cellular kinases. The activated transcription factors 
induce the transcription of the IFN genes after the translocation into nucleus (Kawai and Akira, 
2010). In addition, the type I IFNs can also be induced by host factors such as tumor necrosis factor 
(TNF), which signals using IRF1 (Yarilina et al., 2008). After their induction, the interferons exert 
the antiviral effect in neighbouring and infected cells by utilization of different receptors including 
IFN-αR1/R2 for type I IFNs, IFN-γR1/R2 for type II IFN and IFN-λR1 for type III IFN (Kotenko 
et al., 2003, Sheppard et al., 2003). For example, binding of type I IFN to IFNAR activates the 
transcription factors named STAT1 and STAT2 (signal transducer and activator of transcription 1 
and 2) through the activated receptor-associated protein tyrosine kinases Janus kinase I (JAK1) 
and Tyrosine kinase 2 (TYK2) (Balachandran et al., 2000). Phosphorylated STAT1 and STAT2 
translocate into the nucleus, binds to DNA sequences known as IFN-stimulated response element 
(ISREs) together with IRF9 and result in the transcription of over 300 interferon stimulated genes 
(ISGs) (Schoggins et al., 2011). The ISGs interfere with various steps of virus infection including 
virus entry, virus replication and viral protein translation (Fig. 1.4) (Bowie and Unterholzner, 
2008). For example, 2’-5’ oligoadenylate  
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Figure 1.4 Activation of the interferon response and IFN-induced antiviral mechanisms 
(Bowie and Unterholzner, 2008). 
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synthetase (OAS) is an IFN stimulated gene which leads to the degradation of viral RNA 
(Rutherford et al., 1988). OAS produces 2’-5’ oligoadenylates which activate the RNaseL, leading 
to the cleavage of the viral RNA in cytosol and inhibition of viral protein synthesis (Silverman, 
2007). In addition, the cleaved products of RNase L have been found to activate the RLRs by 
functioning as ligands for RIG-I and MDA5 (Malathi et al., 2007). Moreover, RNase L has been 
found to be primarily responsible for IFN antiviral activity during influenza virus infection, but 
the roles of OAS and RNase L in restriction of DNA virus infection remain unclear (Malathi et al., 
2007). Protein kinase R (PKR) is a serine/threonine kinase, which also has been found to be 
involved in the inhibition of viral protein translation through phosphorylation of the eukaryotic 
translation initiation factor 2 α (eIF2α), it can also mediate apoptosis, cell-growth arrest, and 
autophagy to control viral replication and spread (Sadler and Williams, 2007). 
Orthomyxovirus Resistance Gene (Mx) proteins named MxA and MxB have been 
identified in human, and related Mx proteins namely Mx1 and Mx2 have been reported in mice 
(Haller et al., 2007). They show antiviral activities against several viruses including 
orthomyxomaviruses, paramyxomaviruses, rhabdoviruses, togaviruses and bunyaviruses,   
probably by blocking the early steps of viral replication through mediating the vesicle trafficking 
to trap essential viral components (Haller et al., 2015). For example, overexpression of human 
MxA protects IFN-αβR -deficient mice from fatal infection with Thogoto virus, influenza virus, 
VSV, LaCrosse virus, Semliki and Forest virus (Hefti et al., 1999, Pavlovic et al., 1990, Pavlovic 
et al., 1995). The ISG15 is an ubiquitin-like protein that mediates ISGylation of targeted viral 
proteins (Der et al., 1998). For example, the ISGylation of human papillomavirus L1 capsid protein 
plays an essential role in the inhibition of HPV16 pseudoviruses infectivity (Durfee et al., 2010). 
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In addition, studies have shown that ISG15 deficient mice have increased susceptibility to virus 
infection including herpes virus, influenza and sindbis viruses (Lenschow et al., 2007).  
Tetherin and Viperin are important ISGs that inhibit virus infection by the restricting virus 
release. Tetherin is a GPI-anchored protein that has been shown to inhibit the release of some 
retrovirus, filovirus, arenavirus members (Gnirss et al., 2015, Neil et al., 2008, Venkatesh and 
Bieniasz, 2013). Viperin is known to prevent the replication of various viruses including HCMV, 
influenza virus, hepatitis C virus, dengue virus, alphaviruses, and HIV-1 (Fitzgerald, 2011).  
In addition, type I IFN-independent antiviral mechanisms including RNA interference 
(RNAi) and autophagy have been reported.  RNAi antiviral mechanism was identified in plants, 
fungi, nematodes and insects, but not in infected mammalian cells (Li and Ding, 2006). However, 
RNAi suppressor proteins have been reported to be produced by various plants and invertebrate 
viruses (Agrawal et al., 2003). Dicer endonuclease members recognize and process viral dsRNA 
into siRNA, which mediate the cleavage and degradation of viral RNA (Agrawal et al., 2003). 
Autophagy has been found to be involved in the lysosomal degradation of cytosolic organelles, 
which are important for the cellular homeostasis (Deretic and Levine, 2009). Studies have 
illustrated that signalling through PRRs can lead to the induction of autophagy, resulting in the 
engulfing of intracellular virion or viral products into autophagosome and their degradation in the 
lysosome, which is referred to "xenophagy" (Levine and Deretic, 2007). This antiviral mechanism 
has been shown to be crucial to protect Drosophila from infection by VSV (Shelly et al., 2009).  
1.2.3 Virus-mediated modulation of innate immunity 
Most viruses possess two major mechanisms to counteract the innate immune responses at 
multiple stages. First is the general inhibition of cellular protein expression. In this mechanism, 
some RNA viruses such as picornaviruses, influenza viruses, and rhabdoviruses have been shown 
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to block general expression of cellular genes with antiviral functions through diverse viral proteins 
(Lyles, 2000). For example, the VSV M protein has been shown to interfere with multiple steps in 
host gene expression including transcription, host RNA processing and transportation (Her et al., 
1997).   
Second is the interference with molecules involved in the IFN signaling through 
sequestration or disruption (Versteeg and García-Sastre, 2010). In this mechanism, multiple 
components in the IFN signalling can be targets for various viruses such as the initial PRR sensors 
and Interferon regulatory factors (IRFs). For example, the poliovirus 3Cpro protease and the EBOV 
(Ebola virus) VP35 protein can lead to the degradation of RIG-I senor or blocking of viral RNA 
sensing through RIG-I respectively (Chan and Gack, 2016). The Rabies virus protein P and 
Hepatitis E virus RF3 can prevent the phosphorylation of IRF3 and IRF7 respectively (Chan and 
Gack, 2016, Pfaller and Conzelmann, 2008).   
1.2.4 Adenovirus-induced host innate immune responses   
  Adenoviruses have been shown to induce intensive innate and adaptive immune responses, 
which hamper both the efficiency and safety of the use of adenovirus as gene delivery vectors 
(Shayakhmetov et al., 2010). Thus, it is important to identify the viral and cellular components 
which are involved in the antiviral responses. Currently, many mechanisms have been reported to 
be involved in the adenovirus-induced innate immune responses, including Toll- 
 
 
 
 
32 
 
 
Figure 1.5 Adenovirus-induced host innate responses (Hendrickx et al., 2014) 
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Like Receptor dependent mechanisms, and some other Toll- Like receptor independent 
mechanisms (Fig. 1.5).  
It has been reported that innate immune responses can be detected right after the application 
of adenovirus into human and nonhuman mammals (Raper et al., 2003, Schnell et al., 2001). 
Moreover, it has been suggested that adenovirus-induced innate immune responses are dose-
dependent and without the requirement of viral gene expression (Schnell et al., 2001, Stilwell et 
al., 2003).Mechanisms of adenovirus sensing have been suggested to engage many different 
sensors, which are often cell-specific. In plasmacytoid dendritic cells (pDCs) which are the 
principal producer of type I IFNs, TLR9 and MyD88 were suggested to be involved in the sense 
of  HAdV-B by recognition of viral DNA ( Zhu et al., 2007). In addition, TLR2-knockout mice 
showed diminished NF-kB activation and humoral responses to human adenoviruses (Appledorn 
et al., 2008b) suggesting involvement of TLR2.  
The innate immunity induced by HAdV-5 infection has been found to be mediated by 
TLR4 (Doronin et al., 2012). Since studies showed that CD46-utilizing adenovirus (Ad5.F16) was 
preferential to stimulate TLR9-mediated innate responses than CAR-utilizing adenovirus 
(Ad5.F5), a connection between the activation of TLR signalling and cell entry pathways mediated 
by specific receptors has also been suggested to exist (Iacobelli-Martinez and Nemerow, 2007). 
However, the underlying mechanisms by which cell entry pathways affect innate immune 
responses against adenoviruses remain unclear. Furthermore, studies have shown that while 
transcription factor interferon response factor 3 (IRF-3) is critically involved in sensing adenovirus 
genomic DNA in murine bone marrow-derived macrophages (Nociari et al., 2007), IRF7 is also 
critical to mediate adenovirus-induced type I-IFN response in-vivo by using adenovirus infected 
mice deficient for IRF3 or IRF7 (Fejer et al., 2008, Nociari et al., 2007). Other pathways 
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independent of TLR signalling are suggested to be involved as mice deficient in TLR-adaptors 
TRIF and MyD88 also induced the immune responses against HAdV-3 (Fejer et al., 2008). Two 
inflammasome-associated DNA sensors AIM2 (absent in melanoma 2) and NALP3 have been 
found to be involved in HAdV-infected myeloid cells through the recognition of HAdV DNA 
(Stein and Falck-Pedersen, 2012). AIM2 appears to be involved in the adenovirus-induced innate 
immune response (Stein and Falck-Pedersen, 2012). The activation of NLRP3 inflammasome was 
also shown in human adenovirus type 5 (Ad5) infected THP1 cells (Barlan et al., 2011) or 
transfection of Ad5 DNA into human keratinocytes (Schulte et al., 2013).  
In addition, various cytosolic DNA sensors have been reported in anti-adenoviral response 
(Fig. 1.5). The knockdown of DDX41 or STING in mouse DCs significantly decreased the type I 
IFN response against HAdV infection (Zhang et al., 2011). In addition, the knockdown of DDX41 
in the HAdV-5 infected RAW 264.7 murine macrophage-like cells resulted in dramatic reduction 
in the phosphorylation of transcription factor interferon response factor 3 (IRF3), which is a 
primary antiviral response marker (Stein and Falck-Pedersen, 2012). All these evidence suggest 
that DDX41 is involved in the recognition of HAdV DNA in certain cells. Recently, knockdown 
of cGAS, TBK1 or STING reduced the phosphorylation of interferon response factor 3 (IRF3) 
after infection by HAdV-5 (Ad5CiG) suggested that cGAS (Cyclic GMP-AMP synthase), a DNA 
sensor that produces a cyclic guanine-adenine dinucleotide (cGAMP), TBK1 kinase and adapter 
molecule STING are also involved in sensing HAdV DNA in murine RAW 264.7 macrophage-
like cells (Lam et al., 2014). These studies suggested that cGAS is an additional cytosolic PRR 
involved in adenovirus infection, which is responsible for detection of internalized adenovirus 
DNA to induce the type I interferon response. Moreover, RIG-I has also been found to mediate the 
activation of innate immune responses against adenovirus infection. Studies have shown that the 
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adenoviral genome encodes two RNA by host RNA polymerase III, namely virus associated RNA 
I (VA-I) and VA-II with the size of 157 and 158 nucleotides respectively, VA-I and VA-II were 
found to bind to RIG-I upon transfection (Minamitani et al., 2011, Weber et al., 2013). Moreover, 
unknown cytosolic DNA sensors have also been suggested to sense adenovirus DNA in 
conventional DCs (Zhu et al., 2007). 
1.2.5 Modulation of Innate immune response by adenovirus  
So far, proteins encoded by early (E) regions E1, E3 and E4 regions, the VA-RNAs and 
viral structural proteins VI and VII have been demonstrated to act as innate antiviral response 
antagonists (Schreiner et al., 2012, Weitzman and Ornelles, 2005).  
Multiple HAdV genes have been found to counteract host immune responses. E1A 
produced proteins have been shown involved in the apoptosis, immune evasion, and other viral 
gene expression (Berk, 1986, Burgert et al., 1987). Specifically, E1A can inhibit the IFN-α-
activated antiviral response since E1A has been found to interfere with the formation of the crucial 
ISGF3 transcriptional complex which has been found to activate the transcription of downstream 
antiviral genes through binding to ISREs (Darnell Jr et al., 1994). This has also been confirmed by 
studies showing that E1A can rescue other viruses from the effects of IFN response by inhibiting 
the formation of the ISGF3 complex (Kalvakolanu et al., 1991). Moreover, E1A inhibits 
transcription of JAK1, which is essential for signaling for some type I and type II cytokine in 
epithelial cells (Shi et al., 2007). In addition, E1A has been reported to be involved in the 
suppression of ISG activation through interfering with the ISG transcription (Fonseca et al., 2012). 
E1A can also reduce antigen presentation in infected cells through interference with the peptides 
presentation to the immunoproteasome. Studies showed that two E1B proteins E1B-19K and E1B-
55K proteins can block the tumor suppressor protein p53-mediated apoptosis and help the virus to 
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persist in an infected host (Sabbatiniet al., 1995; Teodoro and Branton, 1997, Chahal et al., 2013). 
In addition, E1B-55K interferes with the induction of ISG genes as HAdVs lacking 55K protein 
are notably sensitive to type I IFN (Chahal et al., 2012). Furthermore, E1B-55K together with 
E4orf6 protein forms a complex to block the DNA damage signaling through the immobilization 
of damage sensor during virus infection and degradation of the antiviral factor SPOC1 involved in 
DNA damage response by the proteasome thereby leading to the increase of virus yield in infected 
cells (Carson et al., 2009, Schreiner et al., 2013).  
E3 proteins are known for the immunomodulatory functions. E3-14.7K and E3-6.7K 
interfere with the cytolytic and pro-inflammatory activities by inhibiting the NF-κB induced 
transcription of inflammatory mediator (Carmody et al., 2006). E3-49K has been found to inhibit 
peptide presentation by MHC class I through retargeting of MHC I to the endoplasmic reticulum 
(Jackson et al., 1993), it also has immunomodulatory functions as  it reduces the expression of 
activation markers on NK cells, and inhibits the activation of T cell receptor (Windheim et al., 
2013). 
Some E4 proteins are involved in the regulation of apoptosis and antiviral responses. For 
example, E4orf6 together with E1B-55K can block the DNA damage signaling as a complex 
(Carson et al., 2009, Schreiner et al., 2013). In addition, E4orf3 can inhibit IFN production through 
disrupting the PML-ND (promyelocyticleukemia protein bodies) function, which is important for 
virus detection in antiviral innate immunity (Bernardi and Pandolfi, 2007). Moreover, E4orf3 is 
suggested to antagonize species-specific innate immune responses against adenoviruses 
(Hendrickx et al., 2014b). 
Recently, viral protein VII has been found to have an impact on antiviral responses in 
human cells through the formation of complexes with nucleosomes and limitation of DNA 
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accessibility (Avgousti et al., 2016). Both in-vitro and in-vivo studies showed that protein VII 
sequesters HMGB1 protein, which is inflammation-induced and functions as antiviral immune 
responses activation signal via direct protein interaction (Lotze and Tracey, 2005). In addition to 
these antagonist proteins, HAdV VA-RNAs (non-coding virus-associated RNA) also have been 
found to modulate host IFN responses by blocking dsRNA-activated protein kinase R (PKR) 
activity (Mahr and Gooding, 1999, Wold et al., 1999). 
1.2.6 Attempts to modify AdV vectors to diminish immune responses          
Currently, various viral vectors derived from adenoviruses, adeno-associated viruses, 
retroviruses, lentiviruses, herpes simplex viruses have been studied in clinical trials over the 
decades (Appaiahgari and Vrati, 2015, Giacca and Zacchigna, 2012) (Table 1.). 
Adenoviruses are one of the most intensively studied vectors in decades for gene therapy 
and vaccination as they have been shown to have several advantages, for example they can infect 
a broad range of dividing and non-dividing cells, can be grown to high titers easily and their 
molecular biology has been well understood.  Moreover, they can be manipulated to express 
foreign genes with the size up to 37 kb without host genome integration especially HAdV-2 and -
5, which are commonly used as vectors (Bett et al., 1993, Harui et al., 1999, SM Wold and Toth, 
2013). In addition, recently it has been reported that desiccated adenovirus vectors are 
thermostable at 45°C for up to 6 months and can be stored at 4°C for up to 15 months with minimal 
losses in titer or immunogenicity (Alcock et al., 2010). However, further studies and widespread 
utilization of adenoviruses have been hampered because of some disadvantages. The studies have 
indicated that activation of innate immunity by adenoviral vectors both in-vitro and in-vivo is 
associated with significant reduction in the efficacy of gene transfer, as well as notable damage in 
transduced tissue and host (Schnell et al., 2001, Worgall et al., 1997). Often, increase  
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Table 1.1 Major properties with different viral vectors (Thomas et al., 2003). 
Vector Genetic 
Material 
Packaging 
Capacity 
Tropism Vector 
genome 
forms 
Main Limitations  Main advantages 
Retrovirus RNA 8kb Dividing cells only Integrated Only transduces dividing cells; 
integration might induce 
oncogenesis in some applications 
Persistent gene 
transfer in dividing 
cells 
Lentivirus RNA 8kb Broad Integrated Integration might induce 
oncogenesis in some applications 
Persistent gene 
transfer in most 
tissues 
HSV-1 dsDNA 40kb- 
150kb 
Strong for neurons Episomal Inflammatory; transient transgene 
expression in cells other than 
neurons 
Large packaging 
capacity; strong 
tropism for neurons 
AAV ssDNA <5kb Broad, with possible 
exception of 
haematopoietic cells 
Episomal 
and  
Integrated 
Small packaging capacity Non-inflammatory; 
Non-pathogenic 
Adenovirus dsDNA 8kb-30kb Broad Episomal Capsid mediates a potent 
inflammatory response 
Extremely efficient 
transduction of most 
tissues 
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of the vector capacity for foreign gene insertion involves the deletion of other viral genes. Those 
deleted genes are often required for counteraction of host innate immunity and thus may make 
adenovirus vectors more prone to induce strong innate antiviral responses. 
To deliver foreign genes effectively and safely, adenovirus-based vectors are required to 
be engineered with attenuated innate response induction. Although the “gutless” adenoviral 
vectors lacking all viral structural proteins show reduced adaptive immunity and improved gene 
delivery, the innate immunity still remains intact (Brunetti-Pierri et al., 2004, Muruve et al., 2004). 
As such attempts are being made to overcome this limitation by pre-emptive immune modulation 
of the host and further modification of the virus vector. For pre-emptive immune modulation of 
the host, immunosuppressive compounds are always transiently utilized to block general immune 
system or the immune pathways, which are specifically involved in adenovirus infection. For 
example, pre-treatment with anti-inflammatory glucocorticoid such as dexamethasone (DEX) 
before systemic adenovirus administration block adenovirus-triggered innate immune responses 
including pro-inflammatory gene induction in liver / spleen tissues, cytokine induction, and 
reduced adenovirus-specific humoral responses (Seregin et al., 2009). In addition, it has shown 
that pre-treatment with liposome-encapsulated clodronate results in transient depletion of 
macrophages, reduced induction of cytokines and chemokines (IL-6 and RANTES) leading to 
enhanced adenovirus-based hepatic gene delivery (Kuzmin et al., 1997, Zhang et al., 2001). TLR9 
specific-antagonist oligonucleotide ODN-2088 can significantly suppress the induction of 
cytokines such as IL-6 and IL-12 in mice (Cerullo et al., 2007). Furthermore, utilization of the 
neutralizing antibodies to type I IFNs can effectively block the innate and adaptive immune 
responses to adenovirus leading to prolonged foreign gene expression in -vivo (Zhu et al., 2007). 
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Efforts have been made to further modify the adenovirus vector. For example, E3 region, 
which is well known for the immunomodulatory functions is retained in adenovirus vector together 
with appropriate E1-independent promoter since the activity of E3 gene promoter is dependent 
mostly upon trans-activation of E1 gene products. Use of such modified adenovirus in rats showed 
prolonged transgene expression with reduced humoral antiviral responses (Ilan et al., 1997). In 
addition, the modification of adenovirus capsid, has been shown to block the detection of viral 
capsid epitopes such as hexon and fiber (O'Riordan et al., 1999, Roy et al., 1998). For example, 
attaching the polymer polyethylene glycol to the adenovirus capsid (PEGylated HAdVs) have 
shown to reduce adenovirus-triggered innate antiviral responses significantly such as the induction 
of pro-inflammatory cytokines and chemokines (Geest et al., 2005, Wonganan and Croyle, 2010). 
Moreover, studies with PEGylated adenovirus vector injection showed prolonged transgene 
expression in murine livers as well as in the lungs (Croyle et al., 2002). Studies also have shown 
that the use of receptor or tissue specific ligand can reduce the immune response induction in the 
off-target cells or tissues (De Geest et al., 2003, Ding et al., 2002).  
Since conventional adenoviruses induce robust complement activation in-vivo, leading to 
the amplification of innate anti-adenovirus responses and significant activation of humoral 
immune responses, researchers have developed HAdV based vectors with capsid that displays 
peptides with ability to inhibit complement system (Appledorn et al., 2008a, Kiang et al., 2006, 
Tian et al., 2009). For example, a natural complement inhibitor in host cells named DAF (decay 
accelerating factor) has been utilized to modified adenovirus. Intravenous injection of such 
adenovirus (capsid displaying DAF) in mice showed significant reduction in antiviral responses 
including thrombocytopenia and induction of pro-inflammatory cytokines \ chemokines (Seregin 
et al., 2010). 
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Taken together, understanding of the strategies to counteract the antiviral immune 
responses may improve both the efficacy and safety of adenovirus-mediated gene delivery.  
2   HYPOTHESIS AND OBJECTIVES    
Viruses have developed strategies to evade the innate immunity to establish infection. Like 
many other viruses, it has also been shown that adenoviruses modulate the innate immunity 
through expression of adenoviral early proteins E1A, E1B, E3, E4 as well as structural proteins 
pVI and pVII (Avgousti et al., 2016, Burgert et al., 2002, Schreiner et al., 2012).Thus in this 
project, we hypothesized that bovine adenovirus serotype 3 (BAdV-3) also encodes viral proteins 
that are involved in regulating the induction of innate immune response.  
Since innate immune response induction is crucial in early infection of BAdV-3, we 
hypothesized that bovine adenovirus-3 (BAdV-3) structural proteins are involved in the 
suppression of innate immune response. The objective of this project is to identify the potential 
BAdV-3 structural proteins involved in regulating innate immune response, and determine the 
regualtion mechanisms of BAdV-3 induced innate immune response, and also determine the 
pathways involved in BAdV-3 innate immune response regulations. 
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3 BOVINE ADENOVIRUS-3 PROTEINS pV AND pVIII ARE POTENTIAL VIRAL 
SUPPREESORS OF THE INTERFERON RESPONSE 
3.1 INTRODUCTION 
Virus host interaction leads to the induction of cytokines including type I interferons, which 
prevent viral replication by initiating the establishment of an antiviral state in the infected host 
cells (Brubaker et al., 2015). Recognition of pathogen associated molecular patterns (PAMPs) of 
viral nucleic acid (RNA or DNA) by host pattern recognition receptors  leads to the recruitment of 
adapter molecules. This signaling activates certain kinases, which phosphorylate and translocate 
specific transcription factors to the nucleus where they activate the transcription of antiviral genes 
by binding to promoters containing specific transcription factor binding sequences (Kawa and 
Akira, 2009).  
The signaling pathways activated by recognition of RNA by pattern recognition receptors 
including RIG-1 induced gene 1 (RIG-I), melanoma differentiation associated gene 5 (MDA5)  or  
DNA by pattern recognition receptors including DNA-dependent activator of IFN-regulatory 
factors  (DAI), RNA polymerase III, interferon-inducible protein16 (IFI16),  Dead box helicase 41 
(DDX41) , absent in melanoma 2 (AIM 2) and cGAS\STING (Holm et al., 2013; Lam et al., 2014) 
have been reported to activate family of transcription factors including IRF3 (interferon regulatory 
transcription factor), which lead to the induction of IFN-β. Although those different PRRs use 
different adapter molecules, all lead to the activation of IKK (IκB kinase) related kinases including 
TBK1 (TANK binding kinase 1) and IKK (IκB kinase epsilon), which usually result in the 
activation of IRF3 (Clark et al., 2011; Gu et al., 2013) leading to transcriptional activation of 
promoters containing IRF3 binding domains including IFN-β promoter (Honda et al., 2006).  
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Phosphorylation at C-terminal serine \ threonine of cytoplasmic IRF3 leads to the dimerization and 
translocation of IRF3 to the nucleus (Clement et al. 2006; Servant et al. 2003). 
Although PRRs including  DDX41, AIM2, DAI and cGAS have been reported to act as 
cytosolic adenovirus DNA sensors for the induction of type I IFNs (Hendrickx et al., 2014), cGAS 
appears to act as the dominant cytosolic DNA sensor involved in the detection of adenovirus DNA 
in antigen presenting cells (Lam et al.,2014). Moreover, involvement of RIG-1 like receptor 
(MDA5) in the adenovirus induced innate immune response particularly in the induction of type 1 
inferferons has also been reported (Schulte et al., 2013). 
Bovine adenovirus (BAdV)-3 is a non-enveloped icosahedral particle containing 34446 bp 
linear double-stranded DNA genome (Reddy et al., 1998). The icosahedral capsid of adenovirus 
including BAdV-3 is made of major and minor structural proteins (Reddy et al., 1998; Russell, 
2009). In addition, it contains core proteins including pV, which binds to adenovirus genome and 
is involved in connecting the core with capsid proteins (Perez-Vargas et al., 2014, Reddy and 
Nemerow, 2014).  Bovine adenovirus-3 pV, expressed as a 55kDa protein localizes predominantly 
in nucleolus and interacts with 33K protein in virus infected cells (Kulshreshtha and Tikoo, 2008; 
Zhao, 2016). Moreover, BAdV-3 pV appears essential for the production of infectious progeny 
virions (Zhao and Tikoo, 2016). Our results suggest an additional role of viral protein V as 
potential suppressor of the interferon response. 
3.2 MATERIALS AND METHODS 
3.2.1 Cells and viruses   
Madin Darby bovine kidney (MDBK) cells, cotton rat lung (CRL) cells, and CRL.pV (CRL 
cells expressing bovine adenovirus [BAdV]-3 protein V) cells (Zhao and Tikoo, 2016) were grown 
in minimal essential medium (MEM) (Sigma Aldrich) supplied with 10% heat-inactivated fetal 
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bovine serum (FBS, Invitrogen). Bovine monocytes were maintained in AIM-V Serum Free 
Lymphocyte Medium (Invitrogen) containing 10% heat inactivated fetal bovine serum (FBS). 
Mouse embryonic fibroblast (MEF) cells which was kindly provided by Dr. Joyce Wilson, 
University of Saskatchewan, Hela cells, and HEK293T cells (ATCC® CRL-3216TM) were all 
cultivated in Dulbecco’s modified eagle’s medium (DMEM) supplemented with 10% FBS. All 
cell cultures were incubated at 37°C with 5% CO2. BAdV304a (E3 region replaced by GFP gene) 
and BAdV-dV which has the deletion of protein V (Du and Tikoo, 2010, Zhao and Tikoo, 2016) 
were propagated in MDBK or CRL cells with MEM supplemented with 2% FBS and purified by 
cesium chloride density-gradient centrifugation. The virus titer was determined by TCID50 assay. 
3.2.2 Construction of plasmids 
Plasmid expressing hepatitis C virus -NS3/4A (Yu et al., 2010), a well-known inhibitor of 
IFN-β induction as positive control was kindly provided by Dr. Qiang Liu from VIDO-Intervac. 
University of Saskatchewan.  Plasmids expressing BAdV-3 viral proteins V (pcV), VIII (pc.pVIII) 
, 33K (pC.33K), IVa2 (pC.IVa2) and IX (pc.IX) have been described (Zhao and Tikoo, 2016; 
Ayalew et al., 2016; Kulshreshtha et al., 2014; Kulshreshtha et al., 2015). FLAG tagged RIG-I, 
MDA5, TRIF plasmids were kindly provided by Dr. Takashi Fujita, Japan. pEGFP-p65, luciferase 
reporter plasmids (pNF-kB-FireFly Luc or pIRF7-FireFly Luc) encoding luciferase under the NF-
kB  and IRF7 promoter element were kindly provided by Dr. Fengyi Wan, Johns Hopkins 
University. Plasmids pGFP-IRF3, pGFP-IRF7, pEGFPC1-TBK1, pcDNA3-Flag-IKKε and 
luciferase reporter plasmids encoding luciferase under IFN-β promoter (pIFN-β-luc) were kindly 
provided by Dr. Rongtuan Lin from Mcgill University. Plasmids pEY.p1-111(amino acid 1-111), 
pEY.p112-216 (112-216), pEY.p111-148 (111-148), pEY.p142-216 (142-216) cloned into 
pcDNA-EYFP backbone have been described earlier (Gaba, 2016). 
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 Plasmid pcDNA.pVII: A 522bp fragment, which contains gene encoding protein VII was 
amplified by PCR by using primers pVII-R-BamHI and pVII-F-EcoRI (Table 3.1) and plasmid 
PUC304A+ DNA as a template (Anand et al., 2014). The EcoRI-BamHI digested PCR product 
was ligated to EcoRI-BamHI digested plasmid pCDNA3 DNA creating the plasmid pcDNA.pVII 
Plasmid pDsRed.pV: A1280bp fragment which contains gene encoding protein V was 
amplified by PCR by using primers F-XhoI-pV, R-EcoRI-pV (Table 3.1) and plasmid pcV (Zhao 
and Tikoo, 2016) as a template. The EcoRI- XhoI digested PCR product was ligated to EcoRI-
XhoI digested plasmid pDsRed-Monomer-C1 creating the plasmid pDsRedpV.  
Plasmid pDsRed.pVIII: A 659bp fragment, which contains gene encoding protein VIII was 
amplified by PCR by using primers F-XhoI-pVIII and R-EcoRI-pVIII (Table 3.1) and plasmid 
pc.pVIII as template. The EcoRI-XhoI digested PCR product was ligated to EcoRI-BamHI 
digested plasmid pDsRed-Monomer-C1 creating the plasmid pDsRed.pVII.  
Plasmid pCDNA3-HA-IKKε: A 2158bp fragment, which contains gene encoding protein 
IKKε was amplified by PCR by using primers IKKε-F-EcoRI, IKKε-R-NotI (Table 3.1) and 
plasmid pcDNA3-Flag-IKKε DNA as a template. The EcoRI-BamHI digested PCR product was 
ligated to EcoRI-BamHI digested plasmid pcDNA3-HA creating the plasmid pCDNA3-HA- 
IKKε. 
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Table 3.1 List of primers 
_______________________________________________________________________ 
ATGCGGATCCATGATGCATCCCGCTTTACGG                       52K-BamHI-F 
ATGCGAATTCTCAGAATCGCCAGTGGTTAG                                   52k-EcoRI-R 
AGGCGGATCCATGGCCATTCTAATCTCTCCTAG                       pVII-F-BamHI 
ACGCGAATTCTCAAACGGTGTTGCTGACCGTAG                       pVII-R-EcoRI 
GGCCCGAATTCATGCAGAGCACAGCCAATTAC                      IKKε-F-EcoRI 
AATTGCGGCCGCTCAGACATCAGGAGGTGCTGGGACTC             IKKε-R-NotI  
CTCGAGCTATGGCCTCCTCTCGGTTGATTAAAG                       F -XhoI-pV  
GAATTCTTAACGGCGGAGCCGGGTTACTG                                  R-EcoRI-pV  
CTCGAGCTATGAGCAAAGAAATTCCCACACCTTATG          F-XhoI-pVIII  
GAATTCTCAGCTATAACCGCTCACAGAGTTG                      R-EcoRI-pVIII  
ATGACAGCAGAAATGAGTCTTCC                                              IFNAD-1-R1  
ACACACACCTGGTTCAACAC                                                          IFNAD-1-F1  
RTCTGSAGCCAATCCARAAG                                                          IFNβ-F 
CAGGCACACCTGTYGTACTC                                                          IFNβ-R 
AGGCCTCGAGATGAGCAAAGAAATTCCCACACCTTATG         F-XhoI-pVIII-1-111 
ATTAGAATTCTCCGCCCGCGATTTGAGCGC           R-EcoRI-pVIII-1-111 
ATTACTCGAGGGCGCTGCGGGCGATTACTT                     F-XhoI-pVIII-112-216  
GCCGGAATTCTCAGCTATAACCGCTCACAG          R-EcoRI-pVIII-112-216 
ATTACTCGAGGGCGCTGCGGGCGATTACTT                                F-XhoI-pVIII-112-146  
ATCCGAATTCCGAGCCTCCTCCTAGTTGAA          R-EcoRI-pVIII-112-146 
ATTCCTCGAGGCGTTCATCTTTCAACCCCC          F-XhoI-pVIII-147-216  
GCCGGAATTCTCAGCTATAACCGCTCACAG                     R-EcoRI-pVIII-147-216 
_____________________________________________________________________________ 
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3.2.3 Transfection 
HeLa cells, HEK293T cells and MEF cells were transfected with various plasmids using 
Lipofactamine 2000 or 3000 reagents (Invitrogen) as described by the manufacturer. 
For analysis of the IFN-β promoter activity, HEK293T cells or MEF cells grown in 24-
well tissue culture plate at a density of 2×105 cells per well were co-transfected with 120 ng 
reporter plasmid pIFNβ-Rennilaluc-IRES-Fireflyluc DNA and with either 300 ng plasmid DNA 
expressing individual viral protein or 300 ng of control plasmid. At 20 hrs post-transfection, the 
cells were left untreated or further treated with 300 ng poly I:C (Polyinosinic-polycytidylic acid, 
InvivoGen) or poly dA:dT (a synthetic analog of B-DNA, InvivoGen). After 20 hrs of incubation, 
the samples were analyzed by dual luciferase reporter assay.  
For the analysis of involved pathways, HEK293T cells  grown in 24-well plate at a density 
of 2×105 cells per well were co-transfected with  300ng plasmid DNA pCDNA3 or pcV or 
pc.pVIII individually, 120 ng of reporter plasmid  pIFNβ-Rennilaluc-IRES-Fireflyluc and 500 ng 
of plasmid DNA expressing RIG-I (pEF-flag-RIG-I) or  MDA-5  (pEF-flag-MDA5) or TRIF (pEF-
Bos-flag-TRIF) or TBK1 (pEGFPC1-TBK1) or IKKε (pCDNA3-HA-IKKε) individually without 
poly I:C or poly dA:dT stimulation, After 48 hrs of incubation, the cells were harvested for  analysis 
by dual luciferase reporter assay.  
For analysis of the NF-kB and IRF7 promoter activity, HEK293T cells grown in 24-well 
plate at a density of 2×105 cells were co-transfected with 5 ng pCMV-Rennila Luc, and 300ng 
plasmid pCDNA3 or pcV or pc.pVIII individually, and with either 300 ng NF-kB-FireFly Luc or  
IRF7-FireFly Luc. At twenty hrs post-transfection, the cells were treated with 300ng poly I:C. After 
20 hrs of incubation, the cells were analyzed by dual luciferase reporter assays. 
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3.2.4 Luciferase reporter assay  
For dual luciferase reporter assay, the transfected cells were washed with ice-cold 
phosphate-buffered saline (PBS) three times and lysed in 0.1 ml Passive Lysis Buffer (Promega). 
Luciferase reporter gene activities were measured by Dual luciferase assay kit following the 
manufacturer’s instructions (Promega). Relative firefly luciferase activity was analyzed by the 
normalization to Renilla luciferase control. Results were expressed as fold changes compared to the 
empty vector controls. In all experiments, data was a representative of three independent 
experiments. Each experiment was performed in triplicate. 
3.2.5 CsCl gradient centrifugation and Endotoxin quantitation 
Monolayers of MDBK or CRL cells cultured in T-150 flasks were infected with BAdV304a 
or BAdV-dV, respectively at a multiplicity of infection (MOI) of 5. At 40 or 48 hrs post-infection, 
the infected cells were collected in 15ml medium and freeze-thawed for three times. Then, 1.5 ml 
5% Na deoxycholate was added into the cell lysates. After incubating for 30 mins at room 
temperature, 150 µl 2M MgCl2and 75 µl DNase I solution were added. After another 60 mins 
incubation at 37°C, the lysate was subjected to centrifugation at 5000rpm at 4°C for 15 mins and 
the supernatant was subjected to cesium chloride density gradient centrifugation at 35000 rpm at 
10°C for 1 hr. After the first centrifugation, the band that contained virus was collected and then 
subjected to the second centrifugation at 35000 rpm at 4°C for 20 hrs. After the second 
centrifugation, the virus band was collected again and dialyzed for three times with 0.1M Tris-HCl 
overnight in Dialysis Cassettes (Thermo Scientific) to remove the cesium chloride and stored in 
small aliquots at -80°C. Viral titer was calculated by TCID50 assay. LAL Chromogenic Endotoxin 
Quantitation Kit was used to measure the amount of endotoxin in virus stock following the 
manufacturer’s instructions (Thermo Scientific). 
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3.2.6 Immunofluorescence microscopy  
Monolayer of Hela cells cultured in 4-well chamber slides were transfected with 2 µg of 
plasmid DNA expressing DsRed-pV (pDsRed.pV) or DsRed-pVIII (pDsRed.pVIII) respectively. 
At 20 hrs post transfection, the cells were left untreated or treated with poly I:C (1mg/ml). After 
incubating for 12 hrs the cells were washed twice with phosphate-buffered saline (PBS), fixed with 
3.7% paraformaldehyde for 30 min and permeabilized with 0.1 M PBS solution containing 0.5% 
Triton X-100 for 10 min. Then, the cells were incubated with 10% goat serum in PBS for blocking 
for 1 hr at room temperature, and finally incubated with anti-IRF3 mAb (Cell Signalling) and 
Alexa Fluor 488 conjugated goat anti-rabbit IgG antibody  (Invitrogen) for 2 hrs, respectively. 
After final three washes with PBS, the cells were mounted in mounting media (Vector Laboratories 
Inc.) and analyzed with a Leica fluorescence microscope TCS SP5. To determine the localization 
of IRF7 and NF-kB, the Hela cells were transfected with plasmids DNAs expressing GFP-IRF7 
(pGFP-IRF7) and plasmid expressing either BAdV-3 pV (pDsRed.pV) or BAdV-3 pDsRed.pVIII 
individually; or GFP-p65 (pEGFP-p65) and plasmid expressing either BAdV-3 pV (pDsRed.pV) 
or BAdV-3 pDsRed.pVIII individually; and analysed with a Leica fluorescence microscope TCS 
SP5. 
3.2.7 Flow cytometry  
Bovine peripheral blood mononuclear cells (PBMC) were isolated from bovine venous 
blood using Percoll density gradient centrifugation as described earlier (Khosa, 2017).  Purified 
bovine PBMCs resuspended at a density of 1×108 cells/ml were labeled with monoclonal 
antibodies specific for bovine CD11c (BAQ153A), CD14 (Clone MM61A) from VMRD 
(Pullman, WA) for 20 min at 4°C and remixing every 10 minutes gently. The cells were washed 
twice with ice-cold PBSA solution before incubating with fluorochrome-conjugated secondary 
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antibodies (Allophycocyanin (APC)-conjugated rat anti-mouse secondary antibody (BD 
Bioscience) and phycoerythrin (PE)-conjugated goat anti-mouse secondary antibody 
(Thermofisher scientific) for 20 min at 4°C. The cells were washed twice with ice-cold PBSA 
again and re-suspended with PBSA to make a final density of 1×108 cells/ml.  
For monocyte sorting, labelled PBMC cells were filtered through 35 µm cell strainer 
capped 12×75 mm polystyrene round bottom tubes (BD Falcon) to remove cell clumps and isolated 
by a FACScan flow cytometer using the Cell Quest program (Becton Dickinson, Mountain View, 
CA). Sorted monocyte cells were centrifuged and resuspended in AIMV medium supplemented 
with 10% fetal bovine serum. 
3.2.8 Western blotting  
The whole-cell extracts were obtained by two times washing with ice-cold phosphate-
buffered saline (PBS) and lysis with radio-immunoprecipitation assay buffer (1 mM EDTA, 10 
mM Tris-Cl (pH 8.0), 1% Triton X-100, 0.1% sodium deoxycholate, 0.1% SDS, 140 mM NaCl) 
supplemented with protease inhibitors (Roche) and/or phosphatase inhibitor cocktail (Sigma). The 
cell lysates were centrifuged at 13000×g at 4°C for 15 min, and amount of proteins in the 
supernatant was calculated using NanoDrop 2000/2000c Spectrophotometer (Thermofisher 
scientific). Known amount of proteins were separated by sodium dodecyl-sulfate-polyacrylamide 
gel electrophoresis (SDS-PAGE), transferred to nitrocellulose membrane (Bio-Rad) and probed 
by protein specific primary antibodies and Alexa Fluor 680 conjugated goat anti-rabbit secondary 
antibody (Invitrogen) or IRDye800 conjugated goat anti-mouse secondary antibody (Rockland) 
respectively. Finally, the membranes were analyzed by Odyssey® CLx Imaging System (LI-COR).  
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3.2.9 Total RNA extraction and cDNA synthesis  
The isolated monocytes were infected with virus at a MOI of 2. At indicated hrs post 
infection, the infected cells were lysed by adding TRIzol (Life Technologies) following) directly 
to cell culture plates. The RNA was extracted by adding chloroform to the cell lysate in TRIzol, 
vortexing and centrifuging at 14000×g at 4°C for 15 minutes. The aqueous phase was transferred 
to the Eppendorf tube containing 100% isopropanol with glycogen and incubated at -80°C for 5 
min. The RNA pellet was collected by centrifuging at 14000×g at 4°C for 15 min and resuspended 
in 70% ethanol. This step was repeated once with 70% ethanol and then with 100% ethanol. The 
pellet was finally air-dried and resuspended in RNAse-DNAse free water (Invitrogen). Finally, 
RNA quality and quantity was determined using the Agilent 2100 Bioanalyzer (G2938B, Agilent 
technologies).  
The cDNAs were synthesized by reverse transcription using QuantiTect Reverse 
Transcription kit (Qiagen) following the manufacturer’s instructions: About 300 ng of total RNA 
in 12 µl RNAse-DNAse free water (Invitrogen) and. 2 µl of gDNA wipe-out buffer (to eliminate 
genome) were incubated at 42°C for 2 min with GeneAmp 9700 PCR System (Applied 
Biosystems) and placed on ice immediately. The cDNA was generated by adding the prepared mix 
to the wiped RNA (4 µl of Quantiscript RT buffer, 1 µl of reverse transcriptase and 1 µl the primer 
mix). The reaction mix was incubated at 42°C for 30 min and then at 95°C for 3 min with 
GeneAmp 9700 PCR System (Applied Biosystems). 
3.2.10 Quantitative RT-PCR  
Primers used to amplify gene transcripts have been previously described (Rahwa Osman, 
Philip Griebel, unpublished results). For quantitative reverse transcription-PCR (RT-PCR), we 
used PerfeCTa® SYBR® Green SuperMix (Quanta BioScience) with iCycler iQ PCR detection 
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system (Bio-Rad) following the manufacturer’s instructions. Briefly, the reaction was carried out 
in a total volume of 15 µl by using a mix of 15ng cDNA product, 3 µl of the indicated primer set 
at a concentration of 3.3 uM (Table 3.1) and 9 µl of the perfecta SYBR green master mix (2×) 
following the below program: 1 cycle at 50°C for 2 min; 1 cycle at 95°C for 30 s; 45 cycles at 
95°C for 15 s, 60°C for 30 s and 72°C for 30 s. All reactions were performed in triplicate. 
Amplification data of IFNα and IFNβ genes was expressed as threshold cycle (Ct) and relative 
gene expression values were standardized by β-actin reference gene control to obtain ΔCt (ΔCt = 
Ct gene-Ct βactin). 
3.2.11 Co-immunoprecipitation analyses 
HEK-293T cells were co-transfected with different plasmid mix. At 40 hrs post-
transfection, the transfected cells were washed three times with ice-cold phosphate-buffered saline 
(PBS) and then lysed in 200 µl of lysis buffer for 30 min at 4°C (250mM Tris-HCl (pH 7.4), 15mM 
MgCl2, 150mM NaCl, 0.1% NP-40, and 5mM EDTA, 1mM dithiothreitol) supplemented with 
protease inhibitor (Roche). The cell lysates were centrifugated at 1000×g for 10 min at 4°C, and 
the proteins in the supernatants were immunoprecipitated overnight at 4°C with protein specific 
anti-serum and protein G or A sepharose beads (GE Healthcare). The immunoprecipitates were 
washed with 1 ml of lysis buffer for three times and analyzed with immunoblotting procedures 
using indicated specific primary antibodies. 
3.2.12 Statistical analysis 
All experiments were carried out three times independently with triplicate samples each 
time. Data are expressed as means ± SEM and statistical analyses were performed by One way 
ANOVA with Tukey’s Multiple Comparison Test using GraphPad program (GraphPad Software). 
Differences were considered significant at * p<0.05, ** p<0.01 and *** p<0.001. 
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3.3 Results 
3.3.1 BAdV-3 pV and pVIII are involved in the down-regulation of type I IFN response 
To determine whether any BAdV-3 encoded structural proteins have antagonistic effect on 
innate antiviral response, we screened six BAdV-3 proteins by assessing their potential effect on 
the IFN-β promoter activation. HEK293T cells were co-transfected with plasmid pIFNβ-
Rennilaluc-IRES-Firefly luc (luciferase reporter gene under IFNβ promoter) together with plasmid 
expressing individual viral protein or empty control vector. At 20 hrs post transfection, the cells 
were stimulated by transfection with poly I:C (a double-strand RNA analog which is ligand for 
PRRs such as RIG-I,MDA5 and TLR3). After additional incubation for 20 hrs (to activate the IFN-
β promoter activity), the cells were harvested and analyzed for luciferase activity.  As shown in 
Fig 3.1(panel a), poly I:C stimulation enhanced the IFN-β promoter-driven luciferase activity up 
to 30-fold compared with the mock treated control. Interestingly, expression of hepatitis C virus 
NS3/4A, BAdV-3 pV or pVIII significantly inhibited the IFNβ promoter activation. No such 
inhibition could be observed in the cells expressing BAdV-3 pVII, IVa2, pIX or 33K proteins.  
Similarly, stimulation of the MEF cells by transfection of poly dA:dT (act via intracellular 
DNA sensors) enhanced the IFN-β promoter-driven luciferase activity up to 60-fold compared 
with the mock treated control (Fig 3.1, panel b). Moreover, expression of BAdV-3 proteins 
including pV and pVIII significantly inhibited the IFN-β promoter activation (Fig 3.1b). No such 
inhibition could be observed in the cells expressing BAdV-3 pIX or 33K proteins (Fig 3.1b).   
 Since cleaved forms of pVIII are present in the infectious BAdV-3 (Gaba, 2016), we 
determined if different cleavage forms of pVIII are required for inhibiting the activation of IFN-β 
promoter. As seen in Fig 3.2 (panels a, b), unlike full length pVIII, none of the cleaved pVIII forms 
54 
 
expressed in cells transfected with indicated plasmid DNAs down regulated the activation of IFN-
β promoter. 
3.3.2 Protein V antagonizes the IFNs response by disrupting IRF3 signaling  
Since many viruses have been shown to attenuate the type I IFN response by interference 
with the central kinases namely TANK-binding kinase 1 (TBK1) or IκB kinase ε (IKKε) involved 
in the activation of IFN transcription factors, we determined if BAdV3 protein V and VIII also 
have similar antagonistic mechanism to suppress the interferon response. To accomplish this, 
HEK293T cells were co-transfected with indicated amount of luciferase reporter plasmid pIFNβ-
Rennilaluc-IRES-Fireflyluc DNA, plasmid pEGFPC1-TBK1 expressing TANK-binding kinase 1 
(TBK1; activating IFN-β promoter) or plasmid pCDNA3-HA-IKKε expressing IκB kinase ε 
(IKKε; activating IFN-β promoter) together with plasmid expressing either BAdV-3 pV (pcV) or 
pVIII (pcpVIII) protein.  After 40 hrs of transfection, the cell were collected and the cell lysates 
were analysed for luciferase activity. As shown in Fig 3.3 (panels a, b), overexpression of kinases 
TBK1 or Ikkε significantly induced the activation of IFN-β promoter in plasmid pcDNA3 DNA 
(control) transfected cells. The co-expression of pV significantly inhibited the activation of IFN-β 
promoter in cells overexpressing TBK1 kinase but showed no effect in the cells overexpressing 
IKKε kinase. In contrast, co-expression of pVIII significantly inhibited the activation of IFN-β 
promoter in the cells overexpressing TBK1 or IKKε kinases. 
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Figure 3.1 Multiple viral proteins block IFN-β promoter activation triggered by 
poly I:C or poly dA:dT stimulation. HEK293T cells (a) or MEF cells (b) in 24 well 
plate were cotransfected with indicated amount of reporter plasmid pIFNβ-Rennilaluc-
IRES-Fireflyluc and plasmid expressing individual viral protein or empty vector for 20 
hours. Then the cells were stimulated by the transfection with 300 ng poly I:C (a) or poly 
dA:dT (b) for another twenty hours, then the cells were harvested for dual luciferase 
reporter assay. Data is a representative of three independent repeats and expressed as 
means±SEM. Statistical analysis was performed by One way ANOVA with Tukey’s 
Multiple Comparison Test using GraphPad program (GraphPad Software). Immunoblot 
analysis was used to determine the expression of various constructions(c), samples are 
representatives of three triplicates from three independent repeats in both (a) and (b). 
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Figure 3.2 Full length protein VIII is required for the down-regulation of IFN-β 
promoter activity induced by poly I:C stimulation HEK293T cells in 24 well plate were 
co-transfected with indicated amount of reporter plasmid pIFNβ-Rennilaluc-IRES-
Fireflyluc and plasmid expressing different fragement of protein VIII or empty vector for 
20 hours. Then the cells were stimulated by the transfection with 300 ng poly I:C for 
another twenty hours, and the cells were harvested for dual luciferase reporter assay (a). 
Data is a representative of three independent repeats and expressed as means±SEM. 
Statistical analysis was also performed by One way ANOVA with Tukey’s Multiple 
Comparison Test using GraphPad program (GraphPad Software). Immunoblot analysis 
was used to determine the expression of various constructions (b). 
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Figure 3.3 Protein V and VIII significantly downregulate the IFN-β promoter activity 
induced by overexpression of TBK1 or IKKε. HEK293T cells were co-transfected with 
indicated amount of luciferase reporter plasmid pIFNβ-Rennilaluc-IRES-Fireflyluc, plasmid 
expressing TANK-binding kinase 1 (TBK1) or IκB kinase ε (IKKε) together with plasmid 
expressing viral protein V or VIII for forty hours. Then the cell lysates were harvested for dual 
luciferase reporter assay. Data is a representative of three independent repeats and expressed as 
means±SEM (a). Statistical analysis was performed by One way ANOVA with Tukey’s Multiple 
Comparison Test using GraphPad program (GraphPad Software). Immunoblot analysis was used 
to determine the expression of various constructions (b). 
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3.3.3 Protein V interferes with the phosphorylated activation and nuclear translocation of 
IRF-3. 
To examine the effect of BAdV-3 pV or pVIII on the phosphorylation dependent 
transactivation activity of IRF3 (Fig 3.4, panel a), Hela cells were transfected with plasmid 
pCDNA3 (lane 3), pcV (expressing protein V) (lane 4) or plasmid pcpVIII (expressing pVIII) (lane 
5) DNAs. After 30 hrs of transfection, the transfected cells were transfected with poly I:C (1 
mg/ml). After additional incubation for 12 hrs, the cells were collected and analyzed by Western 
blot for expression of phosphorylated IRF3 using antibodies detecting phosphorylated IRF3 
(Ser396) (Fig 3.4, panel a). No phosphorylated IRF3 could be detected in the cells not stimulated 
with poly I:C (lane 1). However, phosphorylated IRF3 could be detected in the cells stimulated 
with poly I:C (lane 2) only. Moreover, no detectable difference could be observed in the amount 
of phosphorylated IRF3 detected after poly I:C stimulation of cells transfected with plasmid 
pcDNA3.1 (control) (lane 3) or plasmid pcpVIII (expressing pVIII, lane 5) DNAs. In contrast, 
significant difference could be observed in the amount of phosphorylated IRF3 detected after poly 
I:C stimulation of the cells transfected with plasmid pcV (expressing pV) DNA (lane 4) compared 
to the cells transfected with plasmid pcDNA3.1 (lane 3) or pcpVIII (expressing pVIII) (lane 5) 
DNAs. 
To examine the effect of BAdV-3 pV or pVIII on  the nuclear translocation of IRF3, Hela 
cells in 4 well chamber slide were transfected with indicated plasmid pDsRed.pV (expressing 
DsRed-pV) or plasmid pDsRed.pVIII (expressing DsRed-pVIII) DNA (Fig 3.4, panel b). At 20 
hrs post transfection, the cells were treated with poly I:C (1 mg/ml). After 12 hrs of incubation, 
the cells were examined by direct fluorescence (panels a1, b1, c1, d1) or indirect fluorescent 
(panels a3, b3, c3, d3) using anti-IRF3 serum. As seen in Fig 3.4 (panel b),  
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Figure 3.4 protein V interferes with the phosphorylated activation and nuclear 
translocation of IRF-3 induced by poly I:C stimulation (a) Hela cells in 6 well plate 
were transfected with empty vector or indicated plasmid DNA expressing protein V or 
VIII (Lanes 3-5) for thirty hrs, then the transfected cells were treated with poly I:C (1 
mg/ml) for another twelve hrs. The cells without poly I:C treatment or only with poly I:C 
treatment without any plasmid transfection were shown as controls (Lane 1-2). 
Immunoblot analysis with antibodies directed against phosphorylated IRF3 (Ser396) and 
total IRF3 was used to determine the phosphorylation level of IRF3. Expression of 
protein V and VIII was also shown by immunoblot analysis. (b) Hela cells in 4-well 
chamber slide were transfected with plasmid DNA expressing DsRed-pV or DsRed-pVIII 
for twenty hours, then the cells were left untreated or treated with poly I:C (1 mg/ml) for 
another 12 hrs. The localization of IRF-3 was analyzed with IRF3 antibody and DNA 
was stained with mounting media.  
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while the IRF3 is localized in the cytoplasm of unstimulated cells (panels a3, a4), the IRF3 
translocates to nucleus in poly I:C stimulated cells (panels b3, b4). Expression of DsRed-pVIII 
(panel c1, c4) does not affect the nuclear localization of IRF3 (panel c3, c4) after poly I:C 
stimulation. In contrast, expression of DsRed-pV (panel d1, d4) significantly inhibits the nuclear 
localization of IRF3 (panel d3, d4) after poly I:C stimulation. 
3.3.4 pV and pVIII suppress the NF-kB or IRF7 promoter activity, but do not prevent 
nuclear translocation of NF-kB or IRF7 
To determine if pV or pVIII affects NF-kB or IRF7 promoter activity, we performed 
luciferase assay using the luciferase reporter plasmids namely pNF-kB-FireFlyLuc or pIRF7-
FireFly Luc that confer NF-kB-dependent or IRF7-dependent inducibility to firefly-luciferase 
expression, respectively. As seen in Fig 3.5 (panels a, c), the expression of pV or pVIII 
significantly reduces the expression of luciferase activity in plasmid pNF-kB-FireFlyLuc DNA 
transfected cells stimulated with poly I:C compared to control (plasmid pcDNA3.1 DNA 
transfected cells). In contrast, expression of pV but not pVIII significantly reduces the expression 
of luciferase in plasmid pIRF7-FireFlyLuc DNA transfected cells stimulated with poly I:C 
compared to control (plasmid pcDNA3.1 DNA transfected cells).  
To determine the effect of pV or pVIII on the nuclear translocation of NF-kB in poly I:C 
stimulated cells, we employed immunofluorescence assay (Fig 3.5b). Hela cells were co-
transfected with plasmid pEGFP-p65 (expressing EGFP-65) (Fig 5b-GFP65, panela3, b3, c3, d3) 
DNAs and either plasmid pDsRed.pV DNA expressing DsRed-pV (panel c1, c4) or plasmid 
pDsRed.pVIII expressing DsRed-pVIII (d1, d4). After 20 hrs post transfection, the cells were 
stimulated by poly I:C for 12 hrs before analyzing the cells by direct immunofluorescence. 
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Figure 3.5 Protein V and VIII suppress the NF-kB and IRF7 promoter activity but do not 
affect the nuclear translocation of NF-kB and IRF7(a) HEK293T cells in 24 well plate were 
cotransfected with indicated amount of plasmid expressing viral protein V or VIII, reporter 
plasmid NF-kB-FireFly Luc or IRF7-FireFly Luc together with pCMV-Renilla as normalization 
control. At twenty hrs post-transfection, the cells were stimulated by the transfection with 300 ng 
poly I:C for another twenty hours before harvested for dual luciferase reporter assay. Data is a 
representative of three independent repeats and expressed as means±SEM. Statistical analysis 
was also performed by One way ANOVA with Tukey’s Multiple Comparison Test using 
GraphPad program (GraphPad Software). (b) Hela cells in 4-well chamber slide were transfected 
with plasmid DNA expressing DsRed-pV or DsRed-pVIII together with plamid expressing GFP-
IRF7 or GFP-p65 for twenty hours, then the cells were left untreated or treated with poly I:C (1 
mg/ml) for another 12 hrs. DNA was stained with mounting media and the localization of 
indicated protein was analyzed by Leica fluorescence microscope TCS SP5. (c)Immunoblot 
analysis was used to determine the expression of various constructions. 
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As seen in Fig 3.5 (panel b-GFP65), the expression of pV (panel c1, c3, c4) or pVIII (panel d1, d3, 
d4) does not alter the nuclear translocation of NF-kB subunit p65 fused to EGFP in poly I:C 
stimulated cells. 
Similar experiment was conducted to determine the effect of pV or pVIII on translocation 
of IRF7 in poly I:C stimulated cells. As seen in Fig 3.5 (panel b-GFP-IRF7), expression of pV 
(panels c1, c3, c4) or pVIII (d1, d3, d4) does not alter the nuclear translocation of IRF7 fused to 
GFP in poly I:C stimulated cells. 
3.3.5 Protein V does not interact with TBK1 or IKKε, but interacts with IRF3 
To explore the possible mechanisms underlying the interference with IRF3 signaling by 
pV, we determined if BAdV-3 pV interacts with kinases TBK1 or IKKε which are primarily 
responsible for the IRF3 activation. HEK293T cells were co-transfected with plasmid pDsRed.pV 
(expressing DsRed-pV) or either plasmid pcDsRed (control) DNAs, and plasmid pEGFPC1-TBK1 
(expressing GFP-TBK1) or plasmid pcDNA3-Flag-IKKε (expressing HA-IKKε) DNAs and 
analyzed by co-immunoprecipitation coupled with Western blotting.   As seen in Fig 3.6 (panel a), 
anti-GFP serum detects GFP-TBK1 specific protein in cells expressing DsRed-pV and GFP-TBK1 
(lane 1) or DsRed and GFP-TBK1 (lane 4). No such protein could be observed in the lysates of 
DsRed-pV and GFP-TBK1 expressing cells immunoprecipitated with anti-pV serum (lane 3) or 
rabbit IgG and probed in Western blot with anti-GFP serum. 
As seen in Fig 3.6 (panel b), anti-HA mAb detects HA-IKKε specific protein in the cells 
expressing HA-IKKε and DsRed-pV (lane 1) or HA-IKKε and DsRed (lane 4). No such protein 
could be observed in the lysates of DsRed-pV and HA-IKKε expressing cells immune-precipitated 
with anti-pV serum (lane 3) or rabbit IgG (lane 2) and probed in Western blot with anti-HA mAb. 
To next determine if pV interacts with IRF3, HEK293T cells were co-transfected 
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Figure 3.6 Protein V does not interact with TBK1 or IKKε directly, but interact with IRF3 
HEK-293T cells were co-transfected with plasmid expressing DsRed-pV(Lanes 1-3) or empty 
vector(Lanes 4-6) together with plamid expressing GFP-TBK1(a) or HA-IKKε(b). At forty hrs 
post-transfection, the transfected cells were harvested for protein immunoprecipitation by 
indicated antibody against protein V (Lanes 3 and 6) or control rabbit serum (Lanes 2 and 5) , and 
immunoblotting analysis was performed with antibodies against GFP(a) or HA(b). Whole cell 
extract was also shown as control by immunoblotting analysis (Lanes 1 and 4). (c)HEK-293T cells 
were co-transfected with plasmid expressing GFP-IRF3 together with plasmid expressing DsRed-
pV (Lanes 4-6) or empty vector (Lanes 1-3). At forty hrs post-transfection, the transfected cells 
were harvested for protein immunoprecipitation by indicated antibody against protein V (Lanes 1 
and 4) or control rabbit serum(Lanes 2 and 5) , and immunoblotting analysis was performed with 
antibodies against GFP. Whole cell extract was shown as control by immunoblotting analysis 
(Lanes 3 and 6). (d)HEK-293T cells were co-transfected with plasmid expressing DsRed-pV 
together with plasmid expressing GFP-IRF3 (Lanes 1-3) or empty vector (Lanes 4-6). At forty hrs 
post-transfection, the transfected cells were harvested for protein immunoprecipitation by 
indicated antibody against GFP (Lanes 3 and 6) or control mouse serum(Lanes 2 and 5) , and 
immunoblotting analysis was performed with antibodies against protein V. Whole cell extract was 
shown as control by immunoblotting analysis (Lanes 1 and 4). 
 
64 
 
pDsRed.pV (expressing DsRed-pV) DNA or either plasmid pcDysRed (control) with plasmid 
pGFP-IRF3 DNA (expressing GFP-IRF3), analyzed by co-immunoprecipitation coupled with 
Western blotting. As seen in Fig 3.6 (panel c), anti-GFP serum detects GFP-IRF3 specific protein 
in cells expressing GFP-IRF3 and DsRed (lane 3) or DsRed-pV (lane 6). Similar protein could be 
observed in the lysates of DsRed-pV and GFP-IRF3 expressing cells immunoprecipitated with 
anti-pV serum (lane 3) and probed in Western blot with anti-GFP serum. As seen in Fig 3.6 (panel 
d), anti-pV serum detects pV specific protein in the cells expressing DsRed-pV and GFP-IRF3 
(lane 1) or pcGFP (lane 4). Similar protein could be observed in the lysates of DsRed-pV and GFP-
IRF3 expressing cells immunoprecipitated with anti-GFP serum (lane 3) and probed in Western 
blot with with anti-pV serum. 
3.3.6 pV and pVIII inhibit IFNβ promoter activity mediated by by RIG-I / MDA-5/ TLR3 
To examine the potential of specific pathways that can be affected by protein V and VIII, 
we assessed the ability of pV and pVIII to block the IFN-β promoter induced by overexpression 
of pathway-specific molecules RIG-I or MDA5 or TRIF (an adaptor molecule downstream of 
TLR3). As seen in Figure 3.7 (panel a), the cells co-transfected with plasmid pIFNβ-Rennilaluc-
IRES-Fireflyluc (luciferase under IFN-β promoter) DNA, plasmid pcDNA3.1 (control) DNA and 
either plasmid pEF-flag-RIG-I DNA expressing RIG-I (lane 1), plasmid pEF-flag-MDA5 DNA 
expressing MDA5 (lane 6) or plasmid pEF-Bos-flag-TRIF DNA expressing TRIF (lane 10) 
resulted in up to 70, 50, 200  fold induction of the IFN-β activity, respectively. In contrast,   
expression of pV (lanes 3,7,11) or pVIII (lanes 4,8,12) led to significant suppression of IFN-β 
promoter activation, in cells co-transfected with plasmid pIFNβ-Rennilaluc-IRES-Fireflyluc and 
either plasmid pEF-flag-RIG-I DNA expressing RIG-I (lane 3,4), plasmid pEF-flag-MDA5 DNA  
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Figure 3.7 Protein V and pVIII inhibit IFNb promoter activity mediated by by RIG-I / 
MDA5/ TLR3. HEK293T cells were co-transfected with indicated amount of luciferase reporter 
plasmid pIFNβ-Rennilaluc-IRES-Fireflyluc, plasmid expressing viral protein V or VIII, plasmid 
expressing RIG-I or MDA5 or TRIF (an adaptor molecule downstreams of TLR3) individually for 
forty hours (a). Then the cell lysates were harvested for dual luciferase reporter assay. Data is a 
representative of three independent repeats and expressed as means±SEM. Statistical analysis was 
performed by One way ANOVA with Tukey’s Multiple Comparison Test using GraphPad program 
(GraphPad Software). Immunoblot analysis was used to determine the expression of various 
constructions (b). 
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expressing MDA5 (lanes 7, 8) or plasmid pEF-Bos-flag-TRIFDNA expressing TRIF (lanes 11,12). 
3.3.7 IFNα and IFNβ transcripts in BAV.dV infected cells 
To determine the impact of protein V on the type I IFN response in virus infected cells, we 
next analyzed the involvement of pV in suppression of IFNβ and IFNα induction in BAV.dV (Zhao 
and Tikoo, 2016) infected cells. MDBK cells in 12 well plate were either mock-infected or infected 
with BAV304a or BAV.dV (pV deleted BAdV-3) at a multiplicity of infection (MOI) of 2. The 
virus stock appeared to be endotoxin free (<0.1 endotoxin unit/mL). At indicated times post 
infection, the total RNA was extracted and used to analyze the transcription levels of IFNα and 
IFNβ by real-time RT-PCR. As seen in Fig 3.8 (panel a), deletion of protein V significantly 
enhanced the level of both IFN-α and IFN-β transcripts at 12 and 24 hrs post of BAdV-dV infection 
of MDBK cells. Same analysis was performed in FACS-isolated bovine monocytes which is the 
most potent cell type to induce type I IFNs during bovine adenovirus infection, and similar result 
was shown in Fig 3.8 (panel b), the deletion of protein V significantly enhanced the level of both 
IFN-α and IFN-β transcripts at 6, 12 and 24 hrs post of BAV.dV infection of bovine monocytes 
cells confirming the Figure 3.1 result by dual luciferase reporter assay that protein V significantly 
suppresses the IFN-β promoter activation, confirming that the type I IFN response could be 
restrained by protein V. 
3.4 DISCUSSION AND CONCLUTION 
Adenovirus infection of host cells induces strong innate immune response including type I 
IFN (Muruve, 2004). To avoid elimination, adenovirus encodes proteins which can help to evade 
the host innate immune response.  So far, structural proteins pVI (Schreiner et al., 2012) and pVII 
(Avgousti et al., 2016) have been shown to aid modulating the innate antiviral response  
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Figure 3.8 Deletion of protein V significantly enhances the transcript level of IFNα and 
IFNβ under BAdV-dV infection. MDBK cells (a) and bovine monocytes (b) in 12 well plate 
were either mock-infected or infected with BAdV-304a or BAdV-dV virus lacking protein V at 
a multiplicity of infection (MOI) of 2 respectively. Total RNA were extracted from the mock-
infected cells and infected cells at the indicated time points 6, 12, 24 hours post-infection, the 
transcription levels of IFNα and IFNβ were analyzed by real-time RT-PCR. The data is expressed 
as relative gene expression value standardized by β-actin reference gene control: ΔCt (ΔCt = Ct 
interest gene-Ct βactin). Data is a representative of three independent repeats and expressed as 
means±SEM. 
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by eliminating the DAXX mediated repression of E1A promoter and elimination of HMGB1 
release from chromatin, respectively. Several early proteins including E1A have been 
demonstrated to inhibit type I IFN inducible gene expression (Ackrill et al.; 1991; Hendrickx et 
al., 2014). Moreover, it has been shown that E1A can also suppress IRF3 dependent induction of 
IFN-\ (Juang et al., 1998). Here, we demonstrate that BAdV-3 structural proteins pV and pVIII 
modulate the activation of IFN-β promoter. Though sensing of adenovirus DNA by cytosolic DNA 
sensor cGAS appears to be dominant mechanism used to induce type I IFN (Lam et al., 2014) in 
virus infected cells, earlier reports indicate that PAMPs of adenovirus nucleic acid are recognized 
by PRRs sensing both cytosolic DNA (e.g cGAS) and cytoplasmic RNA (e,g. RIG-1 like receptors) 
leading to the induction of type I IFN (Muruve, 2004). Nevertheless, those different cGAS and 
RIG-I/MDA5 signaling pathways involve common kinases (TBK1 and IKKε), which activate and 
phosphorylate IRF3 and IRF7 (Wu and Chen, 2014) leading to the activation IFN- or β promoter.  
The IFN-β promoter activity mediated by over expression of RIG-I, MDA5, TLR3 or 
molecules was inhibited by BAdV-3 pV or pVIII. Moreover, BAdV-3 pV or pVIII also 
significantly reduced the activation of IFN-β promoter in the cells stimulated with either poly I:C 
or poly dA:dT. These results suggest that both proteins appear to act at a step common to signal 
pathways used by different PRRs. However, BAdV-3 pV and pVIII appear to act at different 
components of the common step used by different PRR signalling pathways.  
Overexpression of TBK1 but not IKKε did not help in increasing the activation of IFN-β 
promoter in cells expressing BAdV-3 pV, suggesting that pV may suppress the activation of IFN-
β promoter by targeting the activity at IKKε kinase activation or level down stream of TBK1 
activation including activation of interferon regulatory factor(s) (IRF). Although both TBK1 and 
IKKε exibit different substrate specificity and expression pattern, they are indistinguishable in 
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inducing IFN expression (Fitzgerald et al., 2003, Yu et al., 2012) as both TBK1 and IKKε appear 
to possess a partially redundant function in the activation of IFN-β promoter (Hemmi et al., 2004). 
IRF3, a constitutively expressed cytoplasmic protein is a transcription factor, which plays 
an important role in IFN-β signaling pathway leading to the expression of IFN- β (Tsuchida et al., 
2009). Phosphorylation of IRF3 by activated kinaseTBK1 leads to its homo-dimerization and 
translocation into the nucleus, where it binds to IFN-β promoter DNA (Kawai and Akira, 2009). 
Viruses have used a number of mechanisms including binding of viral protein to DDX3 complexed 
to TBK1\IKKε (Schroder et al., 2008), TBK1 scaffolding protein complex (Unterholzner et al., 
2011), directly to TBK1\IKKε (Otsuka et al., 2005) or directly to IRF3 (Zhang et al, 2016) to 
inhibit the activation of IRF3 by TBK1 kinase.  
The significant reduction in the phosphorylation and translocation of IRF3 to the nucleus 
suggest that pV affected the activation of IRF3. It could be due to observed interaction of pV with 
IRF3, which could prevent the interaction between TBK1 and IRF3 required for the activation of 
IRF3. Similar mechanism has been reported for inhibition of IRF3 activation by VP24 of herpes 
simplex virus-1 (Zhang et al, 2016). 
Type I IFN induction is also regulated by transcription factors IRF7 and NF-kB (Levy et 
al., 2011). Although BAdV-3 pV significantly reduced the promoter activity of NF-kB or IRF7, 
there was no effect on the nuclear translocation of NF-kB and IRF7, suggesting that the activation 
of NF-kB and IRF7 transcription factors may not be targeted by the antagonism functions of 
protein V. 
Over expression of TBK1 or IKKε, did not help in increasing the activation of IFN-β 
promoter in cells expressing BAdV-3 pVIII suggesting that pVIII may also suppress the activation 
of IFN-β promoter by targeting the activity down stream of TBK1 and IKKε activation including 
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activation of IRFs. DDX3 binds to IKKε, which leads to TBK1\IKKε mediated IRF activation and 
IFN-β promoter activation (Schroder et al., 2008). Interaction of vaccinia virus K7 protein with 
DDX3 has been reported to abolish such IFN-β promoter activation (Schroder et al., 2008) as K7 
protein binds to N-terminus of DDX3 required for IFN-β promoter activation. Recent report 
demonstrating interaction of BAdV-3 pVIII with DDX3 (Ayalew et al., 2016) led to our 
speculation that such interaction should also inhibit IFN-β promoter activation by suppressing the 
activation of IRFs mediated by TBK1\IKKε. However, pVIII did not lead to the suppression of 
activation of IFN-β transcriptional factors including NF-kB, IRF7 or IRF3. It is possible that the 
motif of DDX3 involved in binding to BAdV-3 pVIII is required for the activation of IFN-β 
promoter activation (Ayalew et al., 2016). Alternatively, it is possible that pVIII may block the 
IFN gene induction at a subsequent step, downstream of IFN transcription factor activation. For 
example, it may interfere with the DNA binding activity of IRF3 (Lin et al., 2001). Future studies 
should explore the possibility if pV and pVIII can interfere with the DNA binding activity of IRF3 
by assessing the function of CBP/p300 transcriptional co-activating proteins, as well as the 
possibility of involvement of DNA sensors such as DDX41 and cGAS in the regulation of IFN 
response by pV and pVIII. 
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